All EMBO Press journals to be fully Open Access as of 1 January 2024 - read the FAQs

Article22 April 2022Open Access
Source DataTransparent process

Astrogenesis in the murine dentate gyrus is a life-long and dynamic process

Julia Schneider

Julia Schneider

Institute of Biochemistry, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany

Contribution: Conceptualization, Data curation, Formal analysis, Validation, ​Investigation, Visualization, Writing - original draft, Writing - review & editing

Search for more papers by this author

Johannes Weigel

Johannes Weigel

Institute of Biochemistry, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany

Contribution: Formal analysis, ​Investigation

Search for more papers by this author

Marie-Theres Wittmann

Marie-Theres Wittmann

Institute of Biochemistry, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany

Institute of Human Genetics, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany

Search for more papers by this author

Pavel Svehla

Pavel Svehla

Institute of Clinical Neuroimmunology, Klinikum der Universität München, Ludwig-Maximilians University Munich, Munich, Germany

Graduate School of Systemic Neurosciences, Ludwig-Maximilians University Munich, Munich, Germany

Medical Faculty, BioMedical Center, Ludwig-Maximilians University Munich, Munich, Germany

Contribution: Formal analysis, ​Investigation

Search for more papers by this author

Sebastian Ehrt

Sebastian Ehrt

Institute of Clinical Neuroimmunology, Klinikum der Universität München, Ludwig-Maximilians University Munich, Munich, Germany

Medical Faculty, BioMedical Center, Ludwig-Maximilians University Munich, Munich, Germany

Contribution: ​Investigation

Search for more papers by this author

Fang Zheng

Fang Zheng

Institute of Physiology and Pathophysiology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany

Contribution: ​Investigation

Search for more papers by this author

Tarek Elmzzahi

Tarek Elmzzahi

Institute of Biochemistry, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany

Department of Molecular Immunology in Neurodegeneration, German Centre for Neurodegenerative Diseases Bonn, Bonn, Germany

Contribution: ​Investigation

Search for more papers by this author

Julian Karpf

Julian Karpf

Institute of Biochemistry, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany

Contribution: ​Investigation

Search for more papers by this author

Lucía Paniagua-Herranz

Lucía Paniagua-Herranz

Department of Molecular Biology, Universidad Complutense de Madrid, Madrid, Spain

Instituto Universitario de Investigación en Neuroquímica (IUIN), Madrid, Spain

Instituto de Investigación Sanitaria San Carlos (IdISSC), Spain

Contribution: ​Investigation

Search for more papers by this author

Onur Basak

Onur Basak

Department of Translational Neuroscience, University Medical Centre Utrecht (UMCU), Utrecht, Netherlands

Contribution: ​Investigation

Search for more papers by this author

Arif Ekici

Arif Ekici

Institute of Human Genetics, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany

Contribution: ​Investigation

Search for more papers by this author

Andre Reis

Andre Reis

Institute of Human Genetics, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany

Contribution: Resources, Funding acquisition

Search for more papers by this author

Christian Alzheimer

Christian Alzheimer

Institute of Physiology and Pathophysiology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany

Contribution: Resources, Funding acquisition

Search for more papers by this author

Felipe Ortega de la O

Felipe Ortega de la O

Department of Molecular Biology, Universidad Complutense de Madrid, Madrid, Spain

Instituto Universitario de Investigación en Neuroquímica (IUIN), Madrid, Spain

Instituto de Investigación Sanitaria San Carlos (IdISSC), Spain

Contribution: Resources, Supervision, Funding acquisition

Search for more papers by this author

Sabine Liebscher

Sabine Liebscher

Institute of Clinical Neuroimmunology, Klinikum der Universität München, Ludwig-Maximilians University Munich, Munich, Germany

Graduate School of Systemic Neurosciences, Ludwig-Maximilians University Munich, Munich, Germany

Medical Faculty, BioMedical Center, Ludwig-Maximilians University Munich, Munich, Germany

Munich Cluster for Systems Neurology (SyNergy), Munich, Germany

Contribution: Resources, Supervision, Funding acquisition

Search for more papers by this author

Ruth Beckervordersandforth

Corresponding Author

Ruth Beckervordersandforth

Institute of Biochemistry, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany

Contribution: Conceptualization, Resources, Data curation, Software, Formal analysis, Supervision, Funding acquisition, Validation, ​Investigation, Visualization, Methodology, Writing - original draft, Project administration, Writing - review & editing

Search for more papers by this author

  • Julia Schneider1,
  • Johannes Weigel1,
  • Marie-Theres Wittmann1,2,
  • Pavel Svehla3,4,5,
  • Sebastian Ehrt3,5,
  • Fang Zheng6,
  • Tarek Elmzzahi1,7,
  • Julian Karpf1,
  • Lucía Paniagua-Herranz8,9,10,
  • Onur Basak11,
  • Arif Ekici2,
  • Andre Reis2,
  • Christian Alzheimer6,
  • Felipe Ortega de la O8,9,10,
  • Sabine Liebscher3,4,5,12 and
  • Ruth Beckervordersandforth *,1
  • 1Institute of Biochemistry, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
  • 2Institute of Human Genetics, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
  • 3Institute of Clinical Neuroimmunology, Klinikum der Universität München, Ludwig-Maximilians University Munich, Munich, Germany
  • 4Graduate School of Systemic Neurosciences, Ludwig-Maximilians University Munich, Munich, Germany
  • 5Medical Faculty, BioMedical Center, Ludwig-Maximilians University Munich, Munich, Germany
  • 6Institute of Physiology and Pathophysiology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
  • 7Department of Molecular Immunology in Neurodegeneration, German Centre for Neurodegenerative Diseases Bonn, Bonn, Germany
  • 8Department of Molecular Biology, Universidad Complutense de Madrid, Madrid, Spain
  • 9Instituto Universitario de Investigación en Neuroquímica (IUIN), Madrid, Spain
  • 10Instituto de Investigación Sanitaria San Carlos (IdISSC), Spain
  • 11Department of Translational Neuroscience, University Medical Centre Utrecht (UMCU), Utrecht, Netherlands
  • 12Munich Cluster for Systems Neurology (SyNergy), Munich, Germany

*Corresponding author. Tel: +49 91318526206; E-mail: [email protected]

The EMBO Journal (2022)41:e110409https://doi.org/10.15252/embj.2021110409

    Abstract

    Astrocytes are highly abundant in the mammalian brain, and their functions are of vital importance for all aspects of development, adaption, and aging of the central nervous system (CNS). Mounting evidence indicates the important contributions of astrocytes to a wide range of neuropathies. Still, our understanding of astrocyte development significantly lags behind that of other CNS cells. We here combine immunohistochemical approaches with genetic fate-mapping, behavioural paradigms, single-cell transcriptomics, and in vivo two-photon imaging, to comprehensively assess the generation and the proliferation of astrocytes in the dentate gyrus (DG) across the life span of a mouse. Astrogenesis in the DG is initiated by radial glia-like neural stem cells giving rise to locally dividing astrocytes that enlarge the astrocyte compartment in an outside-in-pattern. Also in the adult DG, the vast majority of astrogenesis is mediated through the proliferation of local astrocytes. Interestingly, locally dividing astrocytes were able to adapt their proliferation to environmental and behavioral stimuli revealing an unexpected plasticity. Our study establishes astrocytes as enduring plastic elements in DG circuits, implicating a vital contribution of astrocyte dynamics to hippocampal plasticity.

    Synopsis

    image

    Murine dentate gyrus astrocytes derive from neural stem cells and locally divide to establish the astrocytic niche during development. Here, astrogenesis is found to persist to old age, representing a dynamic process mostly driven by local astrocyte proliferation.

    • During postnatal development, astrocytes in the murine dentate gyrus derive from perinatal radial glia-like neural stem cells, and locally proliferate to generate the astrocyte compartment in an outside-in-pattern.
    • Dentate gyrus astrogenesis persists until adulthood and is predominantly driven by locally proliferating astrocytes.
    • Adult astrogenesis is a dynamic process that contributes to a fixed neuron-to-astrocyte ratio within the adult dentate gyrus, which is preserved under pro-neurogenic stimuli.
    • While neurogenesis rapidly declines upon aging, astrogenesis diminishes only much later in life leading to a shift in the neuron-to-astrocyte ratio towards astrogenesis.

    Introduction

    Development, function, and plasticity of neural networks require a fine-tuned orchestration of neurons and glial cells, each of which contributes about 50% to the total cell number of the brain (Herculano-Houzel, 2014). Neurons are considered the key active components in neural circuits facilitating information processing to foster complex processes, such as learning and memory, cognition, and mood through the propagation of electrical signals. Astrocytes, together with oligodendrocytes, belong to the class of macroglia and are vital players regulating the brain’s metabolism, ion homeostasis, and the cross-talk to the periphery by contributing to the formation of the blood–brain barrier (Barres, 2008; Verkhratsky & Nedergaard, 2018). In recent years, it has become evident that astrocytes are in fact more than simply passive bystanders in the brain, but they actively contribute to information processing, by shaping and regulating synaptic connectivity and plasticity, as well as by releasing neurotransmitters and gliotransmitters themselves (Ballabh et al, 2004; Attwell et al, 2010; Eroglu & Barres, 2010; Araque et al, 2014; Chung et al, 2016). Several lines of evidence argue for an important contribution of astrocytes to neuropsychiatric and neurodegenerative diseases (Verkhratsky & Parpura, 2016). In sharp contrast to neurons and oligodendrocytes, and despite the astrocytes importance and abundance in the CNS, very little is known about how astrocytes are generated. Astrogenesis has almost exclusively been studied in the developing cortex and spinal cord (Ge et al, 2012; Tien et al, 2012; Shen et al, 2021), where embryonic neural stem cells (NSCs) called radial glia cells give rise first to neurons and then to glia cells. This so-called neurogenic-to-gliogenic switch occurs during late embryonic development [embryonic day 16.5 (E16.5); (Miller & Gauthier, 2007)] and relies on tightly interlaced mechanisms, which initially repress astrogenesis during the neurogenic phase and later on promote it during peri- and postnatal life (gliogenic phase). Proper neocortical glial expansion emerges postnatally, when seemingly differentiated astrocytes divide symmetrically to generate new astrocytes (Ge et al, 2012; Clavreul et al, 2019). After postnatal development, astrogenesis decays in most brain regions and predominantly persists in neurogenic niches, specialized areas of the brain in which new neurons and glial cells are generated throughout life (Alvarez-Buylla & Lim, 2004; Bond et al, 2015; Kempermann et al, 2015). The dentate gyrus (DG) of the hippocampus is one of those neurogenic regions in the adult brain and represents an excellent model system to study the process of astrogenesis from development to aging.

    The hippocampus, also known as the archicortex, emanates from the dentate neuroepithelium. At late gestational stages, a heterogeneous mixture of neural stem and precursor cells migrates away from the ventricular zone toward the hippocampal fissure, where neural progenitors accumulate and form the anlage of the future DG. At postnatal week two, proliferation becomes more restricted to the developing subgranular zone (SGZ), where radial glia-like NSCs (rNSCs) reside throughout life (Pleasure et al, 2000; Urbán & Guillemot, 2014). The generation and integration of new neurons into existing circuitries is a central process to hippocampal plasticity and involved in higher cognitive functions, such as learning, memory formation, and mood regulation (Ming & Song, 2011; Kempermann et al, 2015). Notably, adult neurogenesis has been reported across mammalian species (Patzke et al, 2015), but its existence in the human brain is a currently highly debated topic with conflicting results (Spalding et al, 2013; Boldrini et al, 2018; Cipriani et al, 2018; Sorrells et al, 2018; Moreno-Jiménez et al, 2019; Seki et al, 2019; Tobin et al, 2019; Franjic et al, 2022). Adult neurogenesis is highly dynamic and can be promoted by physiological stimuli, such as voluntary exercise, which significantly increases the proliferation of neural progenitor cells (van Praag et al, 1999b). During aging, neurogenesis gradually declines due to rNSC pool exhaustion and decreased proliferation of neuronal progenitors until it is fully ceased in aged mice (Kuhn et al, 1996; Seki, 2002; Bondolfi et al, 2004; Garcia et al, 2004; Heine et al, 2004; Encinas et al, 2011).

    Astrocytes are key components of the hippocampal neurogenic niche, and multiple lines of evidence suggest a major impact of astrocytes on DG plasticity by positively regulating rNSCs function and neuronal maturation (Lie et al, 2005; Song et al, 2012; Ehret et al, 2015; Sultan et al, 2015; Schneider et al, 2019). While adult rNSCs and neurogenesis have been in the focus of attention over the last two decades, the generation of astrocytes in the archicortex is a fundamentally understudied process. Like granule neurons, dentate astrocytes originate from developmental and adult rNSCs (Berg et al, 2019). Neurogenesis and astrogenesis in the developing DG occur simultaneously (Bond et al, 2020) in analogy to what has been recently suggested for neocortical development (Shen et al, 2021). During adult stages, astrocytes in the DG are continuously generated either by asymmetric division or trans-differentiation from rNSCs (Bonaguidi et al, 2011; Encinas et al, 2011). With the aim to gain insights into the mechanisms governing astrogenesis, we here assessed basic principles of astrocyte generation and dynamics in the DG throughout the life span of a mouse. Our data reveal that astrocytes originated from perinatal rNSCs, which give rise to proliferating astrocytes expanding the astrocyte compartment. We observed a temporal order in the generation of astrocytes located within different DG compartments, indicating an outside-in-pattern of astrogenesis, as shown already for granule neurons (Mathews et al, 2010). Importantly, our data revealed that the predominant source of newborn astrocytes in the adult DG are not rNSCs, but are locally dividing niche astrocytes, which are able to adapt their proliferation in response to pro- or anti-neurogenic stimuli (voluntary exercise and aging, respectively), thus revealing an unexpectedly high level of astrocyte plasticity.

    Results

    Astrogenesis in the developing murine DG

    To comprehensively understand how and when astrocytes are generated in the developing DG, we here combined genetic fate-mapping with thymidine analogue tracing and cell cycle marker analysis. To unambiguously determine the origin of DG astrocytes, we performed fate-mapping experiments using a tamoxifen-inducible mouse model [NestinCreERT2; (Yamaguchi et al, 2000)], in which the Cre recombinase is expressed in rNSCs. These mice were crossed to a reporter mouse line with a floxed STOP codon in front of a GFP [CAG CAT GFP; (Nakamura et al, 2006)] to monitor recombination events (Fig 1A). These mice will be from now on referred to as NestinCreERT2; GFP animals. Administration of tamoxifen allows to specifically define the timepoint at which the Cre recombinase can enter the nucleus, leading to the expression of the GFP reporter in rNSCs and their progeny. Since the first astrocytes have been reported to arise at the beginning of postnatal development (Bond et al, 2020), we specifically targeted perinatal rNSCs by tamoxifen administration at birth (Fig 1A and B) and analyzed their progeny at postnatal days 3 (P3), P7, P10, and P14 in distinct DG compartments, such as hilus, granular zone (GZ), and molecular layer (ML; Fig 1B). First, we specified whether the NestinCreERT2; GFP mouse line is a valid tool for rNSCs lineage tracing by determining its recombination efficiency and specificity (Fig EV1-EV4). The specificity (number of NESTIN+/GFP+ cells of all GFP+ cells) was 92.61% (Fig EV1A), showing that perinatal rNSCs were the main target of our recombination strategy. Due to their high density, it was impossible to reliably count the number of NESTIN+ cells during early postnatal DG stages. Since perinatal rNSCs were highly proliferative (50.53%; Fig EV1B), we instead estimated the recombination efficiency by assessing the number of proliferating GFP+ cells out of all proliferating cells expressing the cell cycle marker KI67 (Fig EV1C). Using this approach, we observed that recombination occurred in 63.21% of all proliferating cells, in line with previously observed recombination efficiencies in (adult) NESTIN+ rNSCs (Lagace et al, 2007). To identify astrocytes, we performed immunohistochemical stainings against glial fibrillary acidic protein (GFAP), the calcium-binding protein S100β and Acyl-CoA synthetase bubble gum family member 1 (ACSBG1), a marker for gray matter astrocytes in the developing brain (Li et al, 2012; Takeuchi et al, 2020). At P14 and P27, we observed an almost complete overlap between ACSBG1 and GFAP expression in the DG, confirming the specificity of ACSBG1 as an astrocytic marker also in the DG (Fig EV1D). To corroborate that astrocytes derive from NESTIN+ rNSCs, we searched for recombined cells, which downregulated NESTIN, but expressed astrocyte-specific marker. Indeed, we identified cells that co-expressed GFP and ACSBG1, GFAP, or S100β, indicating that NESTIN+ rNSCs give rise to astrocytes in the postnatal DG (Fig 1C). Of note, early postnatal astrocytes predominantly expressed ACSBG1, while GFAP and S100β expression was initiated later (Fig 1C). To investigate the timing of rNSC-derived astrogenesis, the total numbers of ACSBG1+/GFP+ cells were assessed at the specific timepoints (Fig 1D and E). In the first postnatal week, we observed only few ACSBG1+ astrocytes, some of which co-expressed the GFP reporter. The number of GFP+ astrocytes drastically increased at P10 and P14, revealing that rNSC-mediated astrogenesis mainly occurred in the second postnatal week (Fig 1D and E; Table EV1). We corroborated our findings using another astrocyte marker, the enzyme Aldehyde Dehydrogenase 1 Family Member L1 (ALDH1L1; Fig EV1E). In the adult DG, we observed that distinct astrocyte subtypes populate different DG layers (ML, GZ, and hilus), where they exhibit a compartment-specific morphology (Beckervordersandforth et al, 2014). Furthermore, it has been reported that the developing DG is formed in an outside-in layering pattern (Mathews et al, 2010), in which embryonically derived cells contribute preferentially to the outer granule cell layer, while neurons born postnatally remain closer to the hilus (Angevine, 1965; Schlessinger et al, 1975; Bayer, 1980; Crespo et al, 1986). Thus, we next analyzed the time course of astrogenesis in distinct DG layers and observed that the ML was populated by large numbers of astrocytes already at P10, whereas in the GZ and hilus astrocytes appeared only in the subsequent days (Fig 1F; Table EV1). Hence, our data demonstrate that, in analogy to what has been reported for DG neurons (Mathews et al, 2010), rNSCs also generate astrocytes in an outside-in-pattern.

    Details are in the caption following the image

    Figure 1. Astrogenesis in the postnatal dentate gyrus (DG)

    • A. Scheme illustrates developmental fate-mapping experiment using NestinCreERT2; CAG CAT GFP (from now on referred to as NestinCreERT2; GFP) mice to monitor radial glia-like neural stem cells (rNSCs) and their generated progeny.
    • B. Experimental scheme of tamoxifen injection paradigm: perinatal mice were injected twice (12 h apart) to label early perinatal rNSCs and killed at postnatal day (P) 3, 7, 10, or 14 to analyze the rNSC-generated progeny within the DG layers hilus, granular zone (GZ), and molecular layer (ML).
    • C. Confocal images of rNSC-derived astrocytes expressing GFP (green) and astrocyte-specific markers (ACSBG1, GFAP, and S100β; magenta) at different timepoints (P7, P10, and P14); lower pictures depict single-channel images the astrocyte markers (gray) used above.
    • D. Representative pictures of recombined astrocytes (GFP+/ACSBG1+; arrowheads) during DG development (P3, P7, P10, and P14).
    • E, F. Quantification of total numbers of recombined astrocytes (GFP+/ACSBG1+) per area at postnatal timepoints in the total DG (E) or in distinct DG compartments (F), that is, hilus, GZ, and ML indicated by different colors.
    • G. Representative images of proliferating astrocytes (ACSBG1+, cyan; arrowheads) in combination with cell cycle markers KI67 or MCM2 (magenta; P3, P7: KI67; P10, P14: MCM2).
    • H. Confocal image of proliferating astrocytes at P10 (ACSBG1+, cyan; MCM2+, magenta) that did not express NESTIN (white).
    • I, J. Quantification of total proliferating astrocytes (ACSBG1+/KI67+ for P3/P7; ACSBG1+/MCM2+ for P10/P14) per area at distinct timepoints per total DG (I) or hilus, GZ and ML (J).
    • K. Confocal images of proliferating rNSC-derived astrocytes (GFP+/ACSBG1+/MCM2+; arrowheads) at P10.

    Data information: All data are represented as mean ± SEM; number of experimental animals throughout figure: n = 5 (P3) and n = 6 (P7, P10, P14), (E, I) indicated by red dots; all values are indicated in Table EV1; dotted lines mark GZ borders; scale bars (C, H, K) = 10 µm, (D, G) = 50 µm.

    Source data are available online for this figure.

    Details are in the caption following the image

    Figure EV1. Astrogenesis and neurogenesis in the developing DG

    1. Quantification of percentage of NESTIN+ cells out of all recombined cells in the DG of P0-induced NestinCreERT2; GFP mice at P3.
    2. Quantification of percentage of proliferating NESTIN+ cells out of all proliferating cells (KI67+) in the DG of P3 NestinCreERT2; GFP mice.
    3. Quantification of percentage of recombined cells (GFP+) out of all proliferating cells at P3 of P0-induced NestinCreERT2; GFP mice.
    4. Representative images showing that ACSBG1 (magenta) overlapped with GFAP (white) expression at P14 and P27 DG astrocytes.
    5. Representative pictures of recombined astrocytes (GFP+/ALDH1L1+; green and magenta, respectively; arrowheads) at P3, P7, P10, P14 in P0-induced NestinCreERT2; GFP mice.
    6. Confocal pictures of proliferating astrocytes labeled with ALDH1L1 (cyan; arrowheads) and cell cycle markers KI67 or MCM2 (magenta; P3, P7: KI67; P10, P14: MCM2) at distinct timepoints of postnatal DG development in NestinCreERT2; GFP animals.
    7. Representative images of P28 NestinCreERT2; GFP animals, which received one BrdU injection at postnatal day 3, 7, 14, or 21. Most newly generated cells (BrdU+, magenta) were identified as granule neurons (NEUN; cyan), or astrocytes (GFAP; green).
    8. Representative images of DGs at P10 and P14 of NestinCreERT2; GFP animals, which were tamoxifen-induced at P0. Many recombined cells (GFP, green) were identified as proliferating (MCM2+; magenta) IPCs (TBR2+; cyan).

    Data information: All data are represented as mean ± SEM; number of experimental animals (indicated by red dots): (A, C) n = 5, (B) n = 6; dotted lines border SGZ and GZ; scale bars = 50 µm.

    Source data are available online for this figure.

    Details are in the caption following the image

    Figure EV2A. Adult astrogenesis in the murine DG

    1. Representative image of an adult NestinCreERT2; YFP animal, which was populated by astrocytes co-expressing SOX2 (magenta) and GFAP (white) in the hilus and GZ.
    2. Quantification of percentages of GFAP+/SOX2+ cells out of all SOX2+ cells in the hilus and GZ.
    3. Confocal picture representing the co-expression of astrocytic marker ACSBG1 (cyan) and SOX2 (magenta) in adult hGFAPeGFP mice.
    4. Quantification of total numbers of rNSCs, IPCs/neuroblasts, and astrocytes generated within 12 days (BrdU+) per area in hGFAPeGFP mice. Cell type identification described below (E).
    5. Single channel images of merged picture in Fig 3B of adult hGFAPeGFP animals, which received BrdU for 12 days in drinking water. Newly generated cells (BrdU+; magenta) were identified as rNSCs [SOX2+ nuclei (cyan) with a GFAP+ radial process (green)], IPCs/neuroblasts [SOX2+ cells in the SGZ (cyan); DCX+ cells in the SGZ and GZ (white); arrows], and astrocytes [SOX2+ cells in the hilus, GZ, and ML (cyan); arrowheads].
    6. Single channel pictures of proliferating astrocytes [MCM2+ (magenta)/SOX2+ (cyan); arrowheads] of adult hGFAPeGFP animals represented a merged picture in Fig 3F.
    7. Confocal images of proliferating astrocytes shown as a merge in Fig 3H that co-expressed MCM2 (white), SOX2 (cyan), GFAP (magenta), and GFP (green) in adult hGFAPeGFP animals. Notably, expression of GFAP was very low in the majority of proliferating astrocytes.
    8. Single channel images of merged picture in Fig 3K. NestinCreERT2; GFP mice received tamoxifen for 5 consecutive days and were killed 12 dpi. Recombined cells (GFP+; green) were identified as rNSCs [(SOX2+ nuclei (cyan) with a NESTIN+ radial process (white)], IPCs/neuroblasts [SOX2+ nuclei in the SGZ (cyan); DCX+ cells in the SGZ and GZ (magenta)], and astrocytes [SOX2+ cells in the hilus, GZ, and ML (cyan)].
    9. Representative image of 9-week-old NestinCreERT2; YFP animals which received BrdU for 12 days in drinking water and were killed immediately after. Generated cells (BrdU+, magenta) were analyzed for co-expression of astrocytic marker SOX2 (cyan). Arrowheads represent newly generated astrocytes.
    10. Quantification of total numbers of generated astrocytes (SOX2+/BrdU+) per area in the hilus and GZ.
    11. Representative image of 9-week-old NestinCreERT2; YFP animals. Proliferating cells (MCM2+, magenta) were analyzed for co-expression of SOX2 (cyan). Arrowhead represents a proliferating astrocyte.
    12. Quantification of total numbers of proliferating astrocytes (SOX2+/MCM2+) per area in the hilus and GZ.

    Data information: All data are represented as mean ± SEM; number of experimental animals (indicated by red dots): (B) n = 3, (D, J, L) n = 5, values are indicated in Tables EV3 and EV4; dotted lines border SGZ and GZ; scale bars = 10 µm (G) and 50 µm (A, C, E, F, H, I, K).

    Source data are available online for this figure.

    Details are in the caption following the image

    Figure EV3A. Adult astrogenesis in vitro and under pro- and anti-neurogenic stimuli

    1. In vitro longitudinal imaging of NSCs cultures of adult hGFAP-RFP animals under differentiating conditions over one week revealed NSC divisions and the generation of both neurons (βIII-TUBULIN, green) and astrocytes (GFAP, red). Tracking of single NCSs was performed using TTT (Hilsenbeck et al, 2016), revealing a lineage tree, which corresponded to the NSC clone shown on the left.
    2. Representative images of 9-week-old NestinCreERT2; YFP animals, which received BrdU in drinking water for 12 days, held under either control or running conditions. Generated cells (BrdU+, magenta) were analyzed for co-expression of astrocytic marker SOX2 (cyan); Arrowheads represent newly generated astrocytes.
    3. Quantification of the total number of newly generated astrocytes (SOX2+/BrdU+) per area in the hilus and GZ of control and running NestinCreERT2; YFP animals. P = 0.0501, unpaired t-test.
    4. Single channel images of merged picture in Fig 4E showing proliferating cells of hGFAPeGFP mice that had access to running wheels or were held under standard housing conditions for 12 days. Proliferating cells (MCM2+; magenta) were identified as rNSCs [SOX2+ nuclei (cyan) with a NESTIN+ radial process (white)], IPCs [SOX2+ nuclei in the SGZ (cyan); arrows], and astrocytes [SOX2+ cells in the hilus, GZ, and ML (cyan) arrowheads].

    Data information: All data are represented as mean ± SEM; number of experimental animals (indicated by red dots): (C) n = 5; values are indicated in Table EV3; dotted lines border SGZ and GZ; scale bars = 50 µm.

    Source data are available online for this figure.

    Details are in the caption following the image

    Figure EV4. Molecular profile of adult astrocytes

    • A–E. tSNE plots showing expression of the enzymes Aldoc (A) and Aldh1L1 (B), the transcription factor Sox9 (C), and the glutamate transporters Slc1a3 (D) and Slc1a2 (E).

    We next asked the question if astrocytes in the developing DG exclusively arise from rNSCs (Brunne et al, 2010, 2013) or whether also non-stem cell astrocytes contribute to astrogenesis in the DG. Co-staining of ACSBG1 in combination with proliferation markers (P3/P7: KI67; P10/P14: MCM2) revealed that the developing DG harboured locally proliferating astrocytes, which did not express the rNSC marker NESTIN (Fig 1G and H). Those numbers strongly increased in the second postnatal week (Fig 1I; Table EV1), as also confirmed by cell cycle marker expression in combination with ALDH1L1 (Fig EV1F). Hence, local astrocytic proliferation strongly contributed to astrogenesis, corroborating findings from neocortical development (Ge et al, 2012). In line with the timing of layer-specific generation of astrocytes (Fig 1F), we observed a strong increase in local astrocytic proliferation first in the ML (P10), while hilus and GZ astrocytes showed the highest proliferation rate at P14 (Fig 1J; Table EV1). To investigate a potential lineage relationship between rNSCs and proliferating astrocytes, we assessed whether rNSC-derived astrocytes (GFP+/ACSBG1+) co-expressed cell cycle markers. Importantly, many proliferating astrocytes expressed the GFP reporter (Fig 1K), indicating that they were indeed rNSC-derived. Together, our data support a lineage hierarchy with a perinatal rNSC at the apex giving rise to locally proliferating astrocytes that successively fill up distinct astrocytic compartments in the second week of postnatal DG development.

    The developing murine DG—a special niche for simultaneous astro- and neurogenesis

    There is conflicting evidence whether or not neurogenesis and astrogenesis in the developing DG occur as temporally segregated processes (Bayer & Altman, 1974; Rickmann et al, 1987; Brunne et al, 2010, 2013; Nicola et al, 2015) or appear simultaneously (Bond et al, 2020). To resolve this debate, we directly correlated timing and ratio between proliferation and generation of rNSCs, neurons, and astrocytes in the developing DG. We first conducted a retrospective analysis, as recently published by Bond et al (2020). Therefore, birth-dating experiments were performed, in which the thymidine analogue bromodeoxyuridine (BrdU) was injected into NestinCreERT2; GFP mice at either P3, P7, P14, or P21 (Fig 2A). At the end of postnatal development (P28), the number and identity of BrdU-incorporated cells were determined, based on morphological features and the expression of cell type-specific markers (Fig 2A and B). rNSCs were identified by the expression of NESTIN and their characteristic morphology: the cell bodies of rNSCs are located in the SGZ and extend a radial process across the GZ. BrdU-incorporating astrocytes in the hilus, GZ, and ML were identified by the lack of a radial process and expression of GFAP (Fig 2B). The vast majority of BrdU+ cells expressed NEUN, a marker for granule neurons (Fig EV1G). Our analysis revealed that rNSCs increasingly incorporated BrdU until P14, which sharply dropped at P21 (Fig 2C; Table EV2). This is in line with findings reporting an increase in rNSC quiescence after postnatal development (Berg et al, 2019). In accordance with Bond et al., we observed both an increase in BrdU+ astrocytes and neurons, strongly arguing for a simultaneous occurrence of neurogenesis and astrogenesis during postnatal DG development [Fig 2C; Table EV2; (Bond et al, 2020)]. However, while postnatal neurogenesis steadily increased until P14, with a subsequent drop at P21 (Fig 2C; Table EV2), astrogenesis increased until P7, followed by a plateau until P14, and a decrease at P21 (Fig 2C; Table EV2). Confirming our fate-mapping results, retrospective BrdU tracing also revealed layer-specific differences in the generation of astrocytes. Astrocytes in the hilus exhibited a prolonged generation until P14 compared with upper DG layer astrocytes (GZ, ML), which peak at P7 (Fig 2D; Table EV2). At P21, astrocytes within all analyzed DG layers showed a strong decrease in BrdU incorporation (Fig 2C; Table EV2), indicating that most astrocytes have been formed by the third week of postnatal development. A limitation of the retrospective analysis is that BrdU is diluted after 2–4 cell divisions (Hughes et al, 1958; Dayer et al, 2003), indicating that we potentially underestimate the number of generated cells since the timepoint of BrdU injection. Therefore, we corroborated our results on the generation of the rNSCs, neurons, and astrocytes at specific timepoints by fate-mapping experiments using NestinCreERT2; GFP mice, which received tamoxifen at P0. Zooming in on the important developmental stages P3, P7, P10, and P14, the number of rNSCs and their newly generated progeny were analyzed by morphology and cell type-specific markers (Fig 2E and F). Recombined rNSCs expressed NESTIN (P3/P7) and GFAP (P10/P14), while recombined astrocytes were identified by the lack of a radial process and expression of ACSBG1 (Fig 2G). Recombined non-glial cells were mainly positive for neuronal markers TBR2 or DCX, representing intermediate progenitor cells (IPCs) and neuroblasts, respectively (Figs 2G and EV1H). At P3, the vast majority of recombined cells were rNSCs, steadily decreasing over time, while the percentage of neurons among recombined cells strongly increased until it reached almost 70% at P14 (Fig 2H; Table EV1). In contrast, only few astrocytes were generated at early postnatal stages, peaked at P10, and evened out at P14 to 14% (Fig 2H; Table EV1). To specifically compare the ratio of proliferating rNSCs, astrocytes, and neuronal precursors out of all proliferating cells, we analyzed cell type-specific marker as described above together with proliferation marker at each postnatal timepoint (P3/P7: KI67; P10/P14: MCM2; Fig 2G). At early stages of DG development, the majority of proliferating cells were rNSCs, which substantially decreased over time (Fig 2I; Table EV1). At P10, we identified a transition from rNSC proliferation to fate-determined progenitor proliferation, which ensured the cell type-specific amplification of both neuronal and astrocytic lineages (Fig 2I, Table EV1). Neuronal precursors initially started to proliferate in the first postnatal week, followed by the astrocytic divisions, which peaked in the second postnatal week (Fig 2I, Table EV1). Our results demonstrate a simultaneous generation of neurons and astrocytes in the developing DG, which is initially accomplished through the proliferation of rNSCs giving rise to both lineages. While rNSC proliferation drops after the first week, in the second postnatal week the amplification of neuronal and astrocytic cell numbers is increasingly mediated by lineage-restricted neuronal precursor and local astrocyte proliferation. Notably, neurogenesis outweighs astrogenesis at all stages during postnatal development, leading to the characteristic overrepresentation of neurons compared with astrocytes in the adult DG.

    Details are in the caption following the image

    Figure 2. Simultaneous occurrence of astrogenesis and neurogenesis in the developing DG

    1. Experimental scheme of birth-dating paradigm used in B-D. NestinCreERT2; GFP mice were injected with the thymidine analog 5-bromo-2-desoxyuridine (BrdU, pink arrows) once at distinct postnatal timepoints of DG development (P3, P7, P14, and P21) and killed at P28.
    2. Representative pictures of P28 animals that received BrdU at P3, P7, P14, or P21. For cell type identification of generated progeny, immunostainings against NESTIN (white), GFAP (green), and BrdU (magenta) were performed. rNSCs were identified as NESTIN+/GFAP+/BrdU+ with a radial process (as indicated with arrows), neurons as NESTIN/GFAP/BrdU+ cells, and astrocytes as NESTIN/GFAP+/BrdU+ cells in the hilus, GZ, and ML (arrowheads).
    3. Quantification of total numbers of generated cell types (rNSCs, neurons, and astrocytes) per area at distinct timepoints as indicated by different colors.
    4. Quantification of total numbers of newly generated astrocytes in the hilus, GZ, and ML at P3, P7, P14, and P21.
    5. Experimental scheme of fate-mapping paradigm used in E-H. Perinatal NestinCreERT2; GFP mice were injected with tamoxifen (twice, 12 h apart) and killed at P3, P7, P10, or P14.
    6. Scheme illustrating that recombined Nestin+ rNSCs can self-renew and give rise to neurons and/or astrocytes.
    7. Representative pictures of immunostainings against cell type-specific proteins (all depicted in white). Recombined cells were identified by GFP, rNSCs by their radial process labeled with NESTIN (P3, P7) or GFAP (P10, P14), astrocytes by ACSBG1, immature neurons expressed DCX, and proliferating cells the cell cycle markers KI67 (P3, P7) or MCM2 (P10, P14).
    8. Quantification of the percentages of GFP+ recombined cell types out of all recombined cells at distinct timepoints. Intermediate precursor cells (IPCs) identified by TBR2 expression (Fig EV1H) were added to DCX+ neuroblasts.
    9. Quantification of the proportions of proliferating cell types (rNSCs, IPCs/neuroblasts, astrocytes) out of all proliferating cells at P3, P7, P10, P14.

    Data information: Values represented as mean ± SEM; number of experimental animals: (C, D) n = 5 (P3, P21), n = 4 (P7, P14); (H, I) n = 5 (P3), n = 6 (P7, P10, P14); all numbers are indicated in Tables EV1 and EV2; dotted lines label GZ borders; scale bars = 50 µm.

    Source data are available online for this figure.

    Astrogenesis persists until adulthood

    During adult life, the neuronal compartment in the DG is progressively augmented by adult rNSCs giving rise to newborn neurons. Even though the generation of new astrocytes from adult rNSCs has been first observed many years ago (Seri et al, 2001; Bonaguidi et al, 2011; Encinas et al, 2011), neither the mode of astrogenesis nor the number of newborn astrocytes have ever been closely examined. Here, we set out to investigate the dimension of astrogenesis and astrocytic lineage progression in the adult DG. First, we compared the quantity of astrocytes generated in the adult DG to the number of newborn neurons by performing BrdU birth-dating. Based on the results of a previous study showing that the maximum amount of BrdU-incorporated astrocytes was reached after 10 days (Encinas et al, 2011), BrdU was administered via drinking water for 12 days to young adult hGFAPeGFP mice [8-week-old; Fig 3A; (Nolte et al, 2001)]. Astrocytes were identified by the expression of GFP, GFAP and sex-determining region Y-box 2 (SOX2). SOX2 is expressed in the vast majority of GFAP+ astrocytes in the hilus and GZ (93.2 and 98.4%, respectively; Fig EV2A and B) and strongly overlapped with ACSBG1 expression in the adult DG (Fig EV2C). However, rNSCs and IPCs in the SGZ also express SOX2. SOX2+/GFAP+ rNSCs were specifically identified by their radial glial process, IPCs and neuroblasts by the expression of SOX2 and DCX, respectively (Fig 3B). After assessing the identity and number of BrdU-incorporated cells (Fig EV2D and E; Table EV3), we calculated the ratio of rNSCs, newly generated IPCs/neuroblasts, and astrocytes. This analysis revealed that very few rNSCs incorporated BrdU, while the vast majority of BrdU+ cells were IPCs/neuroblasts (1 and 91%, respectively; Fig 3C; Table EV3). Nevertheless, a substantial number of astrocytes could be identified among these newly generated cells (7%; Fig 3C; Table EV3). Like done for our analysis during DG development, we investigated the frequency of astrocytes associated with distinct DG compartments within the group of BrdU-incorporating astrocytes. Astrocytes within the hilus made up the majority with 54%, followed by ML astrocytes (32.1%), and GZ astrocytes (13.9%), confirming that newly generated astrocytes are populating all DG layers in adulthood (Fig 3D and E; Table EV4). The vast majority of newly generated and proliferating cells in the SGZ belonged to the neuronal lineage. Hence, astrogenesis was only quantified within the hilus, GZ and ML of the adult DG.

    Details are in the caption following the image

    Figure 3. Astrogenesis persists until adult stages of the DG

    1. Experimental scheme of adult BrdU birth-dating paradigm used in B-E. Adult mice were administered with BrdU via drinking water for 12 consecutive days. For all experiments shown in B-H, adult hGFAPeGFP mice were used.
    2. Confocal image of an adult DG populated by distinct cells identified by cell type-specific protein expression and morphology. All cells newly generated within the 12 days incorporated BrdU (magenta); rNSCs were identified by expression of SOX2 (cyan), localization of their cell bodies to the SGZ, and a GFAP+ radial process (green); IPCs were located within the SGZ and express SOX2 only (cyan); neuroblasts in the SGZ and GZ were labeled by DCX (white; arrows); astrocytes in the hilus, GZ, and ML (arrowheads) expressed SOX2 (cyan). Single channel images are depicted in Fig EV2E.
    3. Quantification of the percentages of generated cell types out of all generated cells (rNSCs, IPCs + neuroblasts, astrocytes) in the DG. Total numbers of all generated cells within 12 days are depicted in Fig EV2D.
    4. Representative picture of astrocytes located to distinct DG layers (hilus, GZ, and ML). Co-expression of BrdU/SOX2/GFAP revealed that all DG compartments harboured astrocytes, which were newly generated during adulthood (arrowheads).
    5. Quantification of the proportions of generated astrocytes per DG layer out of all generated DG astrocytes.
    6. Representative image of proliferating astrocytes (SOX2+/MCM2+; cyan and magenta, respectively; arrowheads) of all DG layers. Singe channel images are depicted in Fig EV2F.
    7. Quantification of the percentages of proliferating astrocytes in distinct DG layers over all proliferating DG astrocytes.
    8. Confocal images showing GFP+/GFAP+/SOX2+ astrocytes of distinct DG layers co-expressing the proliferation marker MCM2 (white; single channels are represented in Fig EV2G).
    9. Scheme illustrating adult fate-mapping experiment using NestinCreERT2; GFP mice to monitor rNSCs and their generated astrocytic progeny. Two potential modes of adult astrogenesis and their lineage relation are depicted: (1) rNSC-derived astrogenesis and (2) astrocyte-derived astrogenesis.
    10. Tamoxifen induction protocol used in (K–N). Adult NestinCreERT2; GFP mice were intraperitoneally injected with tamoxifen for 10 times at 5 consecutive days (12 h apart) and killed 12 dpi.
    11. Representative image of recombined cells (GFP+, green) of different cellular identity: rNSCs [SOX2+ (cyan) with a NESTIN+ radial process (white)], IPCs (SOX2+ nuclei in the SGZ; cyan), DCX+ neuroblasts in the SGZ and GZ (magenta), and astrocytes (SOX2+ cells in the hilus, GZ, and ML; cyan). Single channel images are represented in Fig EV2H.
    12. Quantification of the proportions of recombined cell types over all recombined DG cells (rNSCs, IPCs + neuroblasts, astrocytes).
    13. Quantification of the percentages of rNSC-derived astrocytes in distinct DG layers over all recombined DG astrocytes.
    14. Confocal images of proliferating rNSC-derived astrocytes (GFP+/SOX2+/MCM2+; arrowheads) in hilus and GZ.
    15. Experimental timeline of in vivo two-photon imaging hGFAP-RFP. AAV2/9-hsyn-jGCaMP7 virus served to provide neuronal landmarks and was injected immediately before the implantation of the hippocampal imaging window. Repetitive imaging was performed 28-day post-injection/implantation.
    16. Scheme of hippocampal imaging window facilitating optical access to the DG and even hilus.
    17. Representative examples of field views captured within the hippocampal fissure (indicated by the abundant large vessels), the GZ with its densely packed granule neurons and the hilus containing much larger neuronal somata; expression of GCaMP7 virus (green), labeling of astrocytes by hGFAP-RFP (red).
    18. Examples of locally dividing astrocytes (arrows) derived from two experimental animals. Arrowheads depict landmarks that served for identification.

    Data information: All data are represented as mean ± SEM; number of experimental animals (indicated by red dots): (C, E) n = 5, (G) n = 4, and (L, M) n = 3; numbers are indicated in Tables EV3 and EV4; dotted lines border SGZ and GZ; scale bars = 10 µm (H, N), and 50 µm (B, D, F, K, Q, R). dpi, days post-injection.

    Source data are available online for this figure.

    Next, we wanted to assess where newborn astrocytes originate from. Interestingly, and analogous to DG development, we observed astrocytes expressing the cell cycle marker MCM2 (Figs 3F and EV2F). While proliferating astrocytes were detected in all DG layers, they appeared at a different rate (Figs 3F and G, and EV2F). Hilus astrocytes constituted 61.1% of all proliferating astrocytes, while GZ and ML astrocytes proliferated less (Fig 3G; Table EV4). Dividing GFP+/GFAP+/SOX2+ astrocytes substantially downregulated GFAP protein in many MCM2+ cells, while the expression of hGFAPeGFP and SOX2 was unaltered (Figs 3H and EV2G). Interestingly, the proliferation rate of astrocytes across DG layers (Fig 3G; Table EV4) matched very well with the rate of newly generated astrocytes within different DG compartments (Fig 3E, Table EV4), suggesting that the majority of newly generated astrocytes potentially derive from locally dividing astrocytes.

    To assess to which extent adult astrogenesis is mediated by rNSCs (Fig 3I), we performed fate-mapping experiments using NestinCreERT2; GFP mice (Fig 3I and J). Recombination in rNSCs was induced by 5 days of tamoxifen administration (10×; every 12 h) in 8-week-old mice (Fig 3J). Twelve days post-induction, we observed that the majority of recombined cells (indicated by the GFP reporter) differentiated into DCX+ neuronal cells (62.97%; IPCs and neuroblasts), and a high number of GFP+ cells still retained rNSC identity (32.23%; Figs 3K and L, and EV2H; Table EV3). We rarely observed rNSC-derived astrocytes, contributing to only 0.55% of the total recombined cells (Figs 3K and L, and EV2H; Table EV3). Among those, the vast majority were located in the hilus (93.46% of all recombined astrocytes), few in the GZ (6.54% of all recombined astrocytes), and none in the ML (Fig 3M; Table EV4). Notably, we found few examples of GFP+ astrocytes expressing the cell cycle marker MCM2 (Fig 3N) in the hilus and GZ, suggesting that rNSCs in the adult DG can give rise to astrocytes which can further proliferate. Overall, our data indicate a similar lineage relation as described for postnatal DG development, in which rNSCs generate astrocytes with proliferative capacity that contribute to astrogenesis by local proliferation. However, rNSC-mediated astrogenesis is a rare event in the adult DG and the vast majority of newborn astrocytes are generated by locally dividing astrocytes. Of note, both generation and proliferation of adult astrocytes were confirmed using an additional mouse line (NestinCreERT2; YFP, Fig EV2I–L; Tables EV3 and EV4).

    Given their role as major driver of adult astrogenesis, the next question was how often local astrocytes can proliferate in the adult neurogenic niches. To assess this, we first performed in vitro live imaging of subependymal zone (SEZ) cultures. NSCs from the SEZ of hGFAP-RFP animals were isolated, and time-lapse video microscopy was performed for one week under differentiating conditions. Cell division and lineage progression of individual NSCs were tracked by lineage tree analysis (Costa et al, 2011), and only clones containing astrocytes were further analyzed. These experiments elucidated that astrocytes derived through asymmetric NSC division and were able to divide 1–2 times to produce 2–3 astrocytes (Fig EV3A; Movie EV1). To corroborate our findings in vivo, we next performed intravital two-photon imaging in the adult hippocampus (Fig 3O). To visualize astrocytes, we implanted a hippocampal window in adult hGFAP-RFP mice. During the window surgery, we injected AAV2/9-hsyn-jGCaMP7s to facilitate the expression of the genetically encoded calcium indicator GCaMP7s to serve as anatomical references during in vivo imaging (Fig 3O). After a 4-week waiting period, we repetitively scanned the same region of the dorsal hippocampus spanning the CA1 area up to the DG (up to 750 µm in z; Fig 3O–Q). In agreement with our observation from in vitro imaging, we found that astrocytes in the adult hippocampus nearby the fissure were able to generate 2–3 astrocytes by 1–2 local proliferations (Fig 3R; n = 2 animals). Together, our results show that hippocampal astrogenesis persists into adulthood where it is predominantly driven by local astrocytes proliferation.

    Adult astrogenesis is a dynamic and inducible process

    Adult neurogenesis is not a fixed process but permits cellular and molecular remodeling in response to environmental stimuli. Voluntary physical activity is the most potent known stimulus to enhance adult neurogenesis in the DG, which is mediated by a robust increase in neural stem and progenitor cells proliferation, leading to improved cognitive abilities and mood in animals and in humans (van Praag et al, 2005; van Praag, 2008). Aging on the contrary is regarded as a major negative regulator of adult neurogenesis due to a decrease in progenitor numbers and proliferation capacity, as well as impaired differentiation and survival of newborn neurons (Kuhn et al, 1996; Ben Abdallah et al, 2010; Walter et al, 2011; Lee et al, 2012; Harris et al, 2021). We thus asked if adult astrogenesis is also affected by pro- and anti-neurogenic stimuli (voluntary exercise and aging, respectively) by assessing the number of newly generated and proliferating astrocytes upon voluntary exercise and during aging. For the voluntary exercise paradigm, 8-week-old hGFAPeGFP mice got deliberate access to running wheels for 12 days and the distance traveled was monitored. Littermates without access to running wheels served as controls (Fig 4A). To label newly generated cells, BrdU was administered through drinking water over those 12 days and generated rNSCs, IPCs, and neuroblasts, and astrocytes in the hilus, GZ, and ML of control and running animals were analyzed (Fig 4A and B). In accordance with previous reports (van Praag et al, 1999a, 1999b; Farioli-Vecchioli et al, 2014), access to running wheels significantly increased the number of BrdU-incorporated rNSCs, IPCs, and neuroblasts (Fig 4C, Table EV3). Intriguingly, we also observed a significant increase in the number of BrdU+ astrocytes, indicating that—like adult neurogenesis—adult astrogenesis can be stimulated. Again, we confirmed these observations in an additional mouse line (NestinCreERT2; YFP; Fig EV3B and C; Table EV3). Interestingly, the percentages of newly generated neurons and astrocytes out of all newborn cells did not change between control and exercise conditions (Fig 4D; Table EV3). The adult DG is characterized by an extraordinarily high number of neurons (Bonthius et al, 2004; Keller et al, 2018) and comparatively low number of astrocytes, leading to an estimated neuron-to-astrocyte ratio of approximately 20:1. This ratio is also reflected by the proportion of neurons and astrocytes among newly generated cells with and without a pro-neurogenic stimulus (Fig 4D), suggesting that in the adult DG, neurogenesis and astrogenesis are balanced processes to maintain a stable cellular composition of the DG. Next, we unraveled the source of the additional newly generated astrocytes induced by the running wheel stimulus by assessing the number and identity of proliferating cells (Figs 4E and EV3D; Table EV3). In accordance with published data, showing that the increase in neurogenesis upon running is a direct consequence of the enhanced proliferation of neuronal precursor cells (Kempermann et al, 1997; Kempermann & Gage, 2002; Overall et al, 2013), we observed a significant increase in rNSCs and IPCs upon running (Fig 4E and F, Table EV3). Furthermore, the number of proliferating astrocytes was significantly enhanced in the DG of running mice (Fig 4F, Table EV3), indicating that also under exercise conditions, most adult-born astrocytes derive from locally proliferating astrocytes. To further specify the origin of adult-born astrocytes in running mice, we performed fate-mapping experiments using NestinCreERT2; GFP mice as described above, followed by subsequent access to running wheels for 12 days (Figs 3I and J, and 4G and H). Starting from the same pool of recombined cells, we analyzed the total number of GFP+ rNSCs, IPCs/neuroblasts, and astrocytes (Fig 4H and I). In comparison with animals housed under standard conditions, the runners exhibited an increase in the total number of neuronally determined recombined cells, while the number of rNSC-derived astrocytes did not significantly change (Fig 4H and I; Table EV3). This corroborates the finding that NESTIN+ neural stem and precursor cells primarily contributed to the observed running-induced increase in newborn neurons, while the increase in newly generated astrocytes was rather mediated by the proliferation of local astrocytes.

    Details are in the caption following the image

    Figure 4. Dynamics of adult astrogenesis under pro-neurogenic conditions

    1. Experimental scheme of pro-neurogenic BrdU birth-dating paradigm used in B-D. 8-week-old hGFAPeGFP mice had access to running wheels, controls were housed under standard conditions. All mice were administered with BrdU via drinking water for 12 days and BrdU- incorporation was analyzed at day 12.
    2. Representative images of BrdU-incorporating newly generated cells in control and running hGFAPeGFP animals. BrdU+ cells (magenta) were assigned to distinct cell types: rNSCs [identified by their SOX2+ (cyan) cell bodies residing in the SGZ with a GFAP+ radial process (green)]; IPCs/neuroblasts [SOX2+ (cyan) nuclei located to the SGZ, DCX+ cells (white) in the SGZ and GZ, respectively], and astrocytes [SOX2+ cells (cyan) in the hilus, GZ, and ML]. Arrows mark newly generated neuronally committed cells (BrdU+/DCX+), while arrowheads indicate BrdU+ astrocytes (SOX2+).
    3. Quantification of total numbers of generated cell types (BrdU+) per area in the DGs of control and runner animals. rNSCs: ****P < 0.0001; IPCs/neuroblasts: ***P = 0.0007; astrocytes: **P = 0.0032; unpaired t-test.
    4. Quantification of the percentages of generated cell types out of all generated cells (rNSCs, IPCs + neuroblasts, astrocytes) in the DGs of controls and runners; not significant, unpaired t-test.
    5. Representative images of proliferating (MCM2+; magenta) cells of adult control and running hGFAPeGFP animals; rNSCs, IPCs (arrows) and astrocytes (arrowheads) were identified by criteria described in (B). Single channel images are represented in Fig EV3D.
    6. Quantification of total numbers of proliferating cell types (MCM2+) per area in the DG of controls and runners. rNSCs: **P = 0.0052; IPCs: ***P = 0.0008; astrocytes: *P = 0.0210; unpaired t-test.
    7. Experimental scheme of pro-neurogenic fate-mapping paradigm used in (H, I). 8-week-old NestinCreERT2; GFP mice were intraperitoneally injected with tamoxifen for five days (10 times, every 12 h). After tamoxifen induction, runners had access to running wheels, controls were housed in standard conditions for 12 days after tamoxifen injections.
    8. Representative images of recombined (GFP+; green) cells of distinct cellular identities: rNSCs [SOX2+ (cyan) with a NESTIN+ radial process (white)], IPCs (SOX2+ nuclei in the SGZ; cyan), DCX+ neuroblasts in the SGZ and GZ (magenta), and astrocytes (SOX2+ cells in the hilus, GZ, and ML; cyan).
    9. Quantification of the total numbers of recombined cell types (GFP+) per area in the DG of controls and runners; rNSC: P = 0.074; IPCs/neuroblasts: *P = 0.0460; astrocytes: P = 0.2314; unpaired t-test.

    Data information: All data are represented as mean ± SEM; number of experimental animals (indicated by red dots): (C,D) n = 5 for controls, n = 6 for runners; (F) n = 4 for controls, n = 5 for runners; (I) n = 3 for both controls and runners; numbers are depicted in Table EV3; dotted lines border SGZ and GZ; scale bars = 50 µm.

    Source data are available online for this figure.

    To probe the impact of anti-neurogenic conditions on astrogenesis, we carried out the same experiments in aging mice. Aging has been shown to substantially hamper adult neurogenesis already in middle-aged mice by diminishing both number and maturation of newborn neurons (Kuhn et al, 1996; Heine et al, 2004; Olariu et al, 2007) and depleting the rNSC pool by cell death, terminal differentiation, and increased quiescence (Kempermann et al, 1998; Bondolfi et al, 2004; van Praag et al, 2005; Ben Abdallah et al, 2010; Encinas et al, 2011; Harris et al, 2021). Astrocytes in aged animals display a greater immunoreactivity of GFAP and longer and thicker processes, almost resembling reactive astrocytes (Shetty et al, 2005; Bondi et al, 2021). Besides terminal differentiation of rNSCs into astrocytes (Encinas et al, 2011), nothing is known about how astrogenesis is affected in the aged DG. Using the above-described paradigms (Figs 3A and 4A), we assessed the number and identity of BrdU-incorporating cells in middle-aged (14 months) and aged (21 months) hGFAPeGFP animals (Fig 5A–C). Confirming previous reports, we observed a sharp drop in the total number of BrdU-incorporating rNSCs and neuroblast at 14 months of age (Fig 5C, Table EV3). These numbers did not significantly decline any further at 21 months of age (Fig 5C, Table EV3). To our surprise, the number of BrdU+ astrocytes did not significantly differ between young and middle-aged animals (Fig 5C, Table EV3). Instead, we detected a significant decline in the number of newly generated astrocytes only in aged animals (Fig 5C; Table EV3). While the ratio between newborn neurons and astrocytes was balanced in young adults (both under control and exercise conditions), we now observed a shift toward an increased astrocyte generation (Figs 4D and 5D; Table EV3). However, this shift was not mediated by an increase in astrogenesis per se as the number of proliferating astrocytes was significantly decreased at 14 and 21 months of age (Fig 5E and F; Table EV3). Instead, this shift was mediated by the severe loss (20-fold decline) of proliferating neuronal precursors (Fig 5F; Table EV3). Although the number of proliferating rNSCs was reduced, they did not reach significance (Fig 5F, Table EV3). Further corroborating the cause of the observed phenotypes, we administered tamoxifen to 14-month-old NestinCreERT2; GFP animals and assessed the identity of recombined cells at 12-day-post-injection (dpi) according to previous experiments (Fig 4G–I). Aging led to a significantly reduced number of recombined rNSCs and to a 30-fold decline in neurogenesis (Fig 5G and H; Table EV3). At 14 months, we did not observe a single rNSC-derived astrocyte after 12 days (Fig 5H; Table EV3), an indication that newborn astrocytes during aging originate again predominantly, if not exclusively, from locally proliferating astrocytes.

    Details are in the caption following the image

    Figure 5. Dynamics of adult astrogenesis under anti-neurogenic conditions

    1. Experimental scheme of adult and aging BrdU birth-dating paradigm used in B-D. 8-week-, 14-month-, and 21-month-old hGFAPeGFP animals were administered with BrdU via drinking water for 12 days, and generated (BrdU+) cells were analyzed at day 12.
    2. Representative confocal images of BrdU-incorporating cells (magenta) assigned to distinct cell types of 8-week-, 14-month-, and 21-month-old hGFAPeGFP mice: rNSCs [identified by their SOX2+ (green) cell bodies residing in the SGZ with a GFAP+ radial process (cyan)]; IPCs/neuroblasts [SOX2+ (green) nuclei located to the SGZ, DCX+ cells (white) in the SGZ and GZ, respectively], and astrocytes [SOX2+ cells (green) in the hilus, GZ, and ML].
    3. Quantification of total numbers of generated cell types (BrdU+; rNSCs, IPCs + neuroblasts, astrocytes) per area in the DGs of 8-week-, 14-month-, and 21-month-old hGFAPeGFP animals. rNSCs: ***P = 0.00076, **P = 0.0014; IPCs/neuroblasts ****P < 0.0001; astrocytes: ***P = 0.0008; *P = 0.0403; one-way ANOVA with Tukey’s post hoc test.
    4. Quantification of the percentages of generated cell types out of all generated cells (rNSCs, IPCs + neuroblasts, astrocytes) in the DG of 8-week-, 14-month-, and 21-month-old animals. rNSCs: not significant; IPCs/neuroblasts ****P < 0.0001, ***P = 0.0001; astrocytes: **P < 0.0019, ****P < 0.0001; one-way ANOVA with Tukey’s post hoc test.
    5. Representative images of proliferating cells (MCM2+; magenta): rNSCs [SOX2+ cell nuclei (cyan) residing in the SGZ with a NESTIN+ radial process (white)]; IPCs [SOX2+ nuclei (cyan) located to the SGZ], and astrocytes [SOX2+ cells (cyan) in the hilus, GZ, and ML; arrowheads].
    6. Quantification of total numbers of proliferating (MCM2+) cell types per area in the DGs of 8-week-, 14-month-, and 21-month-old animals. rNSCs: not significant; IPCs ****P < 0.0001; astrocytes: *P = 0.0216; *P = 0.0266; one-way ANOVA with Tukey’s post hoc test.
    7. Confocal images of 8-week- and 14-month-old NestinCreERT2; GFP animals, which received tamoxifen for 5 days (10 times, every 12 h) and were killed 12 days after the last tamoxifen shot. The majority of recombined cells were rNSCs [SOX2+ cell nuclei (cyan) residing in the SGZ with a NESTIN+ radial process (white)] and IPCs/neuroblasts [SOX2+ (cyan) nuclei located to the SGZ, DCX+ cells (magenta) in the SGZ and GZ, respectively], and only very few astrocytes [SOX2+ cells (cyan) in the hilus, GZ, and ML] were generated by initially recombined rNSCs.
    8. Quantification of total numbers of recombined (GFP+) rNSCs, IPCs/neuroblasts, astrocytes per area in the DGs of 8-week- and 14-month-old animals. rNSCs: *P = 0.0460; IPCs/neuroblasts: ****P < 0.0001; astrocytes: not significant; unpaired t-test.

    Data information: All data are represented as mean ± SEM; number of experimental animals (indicated by red dots): (C,D) n = 5 in 8-week-old mice, n = 6 in 14-month-old mice, n = 5 in 21-month-old mice; (F) n = 4 in 8-week-old mice, n = 6 in 14-month- and 21-month-old mice; (H) n = 3 in 8-week-old mice, n = 5 in 14-month-old mice; values are indicated in Table EV3; dotted lines border SGZ and GZ; scale bars = 50 µm.

    Source data are available online for this figure.

    Taken together, our results show that astrogenesis in the DG exists beyond early postnatal stages into adulthood. Even though rNSCs occasionally generate astrocytes, adult astrogenesis is primarily driven by local division of morphologically differentiated astrocytes. Intriguingly, as described for neurogenesis, the process of astrogenesis can adapt to environmental stimuli, suggesting an unexpected level of plasticity of the astrocytic compartment.

    scRNA-sequencing analysis of astrocyte dynamics

    In order to assess astrocyte dynamics on a molecular level, we carried out single-cell RNA sequencing (scRNA-seq) of DG astrocytes of hGFAPeGFP mice. Here, adult animals (8-week-old) held under standard conditions served as controls and were compared with littermates that had access to a running wheel for 12 days and to 14-month-old hGFAPeGFP animals (non-running conditions). For scRNA-seq analysis, we dissected the DGs of 4 animals of each condition (two males and two females). All DGs belonging to the same experimental group were pooled and dissociated to single cells. Around 5000 cells per condition were used for library preparation without any further separation of cell types. scRNA-seq was performed using the droplet-based 10X Genomics platform, and the quality for each sample was controlled by calculating gene counts per cell, UMI counts per cell, and percent of mitochondrial transcripts per cell using the Seurat R package (Butler et al, 2018). Cell clustering was conducted, and the cluster identity was determined by known marker gene expressions (Fig 6A). All expected cell types of the DG could be identified for each condition (Fig 6B). To reveal potential mechanisms underlying astrocyte dynamics observed under distinct conditions, we included only the astrocyte cluster for further analysis, which was identified by the expression of known astrocyte markers such as Aldoc, Aldh1lL1, Sox9, Slc1a3, and Slc1a2 (Fig EV4A–F). First, we observed that clustering of astrocytes did not differ between the conditions, suggesting a common set of transcribed astrocytic genes (Fig 6C). Next, we identified differentially expressed genes comparing (i) young non-runners to young runners (Fig 6D and E) and (ii) young non-runner to aged non-runners (Fig 6F and G). Astrocyte data sets for each condition are summarized in Tables EV5–EV8, and whole scRNA-seq data sets are available at GEO (GSE190399). This analysis revealed only very few significantly differentially regulated genes (Tables EV5–EV8), indicating that overall astrocytic transcription is not significantly affected by distinct stimuli. To still be able to assess subtle transcriptomic alteration, we performed GO-term analysis of all non-significantly differentially regulated genes by a statistical overrepresentation test for biological processes using Panther (https://www.pantherdb.org; Appendix Tables S1 and S2). This analysis revealed the following selected GO-terms as overrepresented in astrocytes isolated from the DG of running mice in comparison with control animals: mRNA processing, RNA splicing, lysosomal transport, regulation of cell growth and others (Fig 6E). Notably, genes associated with gliogenesis, glial cell differentiation, and development, as well as glial cell migration, were statistically overrepresented among the potential upregulated genes in astrocytes from running mice, supporting our observation that astrogenesis by local astrocyte division in running conditions was significantly increased. GO-term analysis of potentially differentially downregulated genes in astrocytes from running mice revealed a strong overrepresentation of terms related to mitochondrial respiration (Fig 6E). Interestingly, the comparison between young adult and aged mice identified many statistically overrepresented GO-terms associated with synapse organization/assembly and axogenesis in DG astrocytes from aged animals alongside epithelial cell differentiation and astrocyte differentiation (Fig 6G). Given that neurogenesis is strongly decreased in 14-month-old animals, these observations indicate that one potential role of astrocytes in the aged DG may be the strengthening of neuronal connection between existing neurons and their maintenance.

    Details are in the caption following the image

    Figure 6. Molecular profile of astrocytes under pro- and anti-neurogenic conditions

    1. tSNE plot of cluster analysis revealed the presence of all expected DG cell types identified by known markers.
    2. DG cell types were present in all three experimental conditions (young non-runner in red; young runner in dark blue; aged in light blue). Box indicates the cluster containing exclusively DG astrocytes.
    3. tSNE plot representing astrocytes in all three experimental conditions.
    4. Comparison of astrocytes derived from the DG of young non-running animals to those of young runners revealed no differential clustering between the two conditions.
    5. Statistical overrepresentation test by Panther; selected Gene Ontology (GO)-terms for biological processes are represented for genes downregulated (red) and upregulated (dark blue) in astrocytes from running mice.
    6. Comparing astrocytes from the DG of young control animals to those of aged mice did not result in differential clustering.
    7. Panther statistical overrepresentation test for selected GO-terms for biological processes for genes downregulated (red) and upregulated (light blue) in astrocytes derived from aged animals.

    Discussion

    While neurogenesis and oligodendrogenesis are well characterized, both in terms of the lineage's progressive differentiation and markers for the specific stages (El Waly et al, 2014; Beckervordersandforth et al, 2015; Bond et al, 2015; Sock & Wegner, 2019), astrogenesis is still a highly understudied process. Two recent publications reported on adult astrogenesis in the diencephalon (Ohlig et al, 2021) and the cortex (Batiuk et al, 2020), using scRNA-seq and clonal analysis. While cortex and diencephalon are non-neurogenic regions of the adult brain, the DG features a specialized form of plasticity due to the life-long generation of new neurons and astrocytes (Suh et al, 2007; Bonaguidi et al, 2011; Encinas et al, 2011). Despite the important regulatory contribution of astrocytes to the process of adult neurogenesis (Song et al, 2002; Lie et al, 2005; Ehret et al, 2015; Schneider et al, 2019), very little is known about the establishment, the maintenance, and the remodeling of the astrocyte compartment in the DG. Implying a vital role of astrocytes to hippocampal function and plasticity, as well as astrocytic contribution to the pathologies of neurodegenerative and neuropsychiatric disorders, we here set out to comprehensively assess astrogenesis and astrocyte dynamics over the life span of a mouse (Fig 7A and B).

    Details are in the caption following the image

    Figure 7. Summary of astrogenesis in the DG from development to aging

    1. Schematics depicting the process of DG astrogenesis along postnatal development. The first astrocytes appeared as early as postnatal day 3 from perinatal neural stem cells. From P10 to P14 astrocyte numbers are constantly increasing also by local astrocyte proliferation leading to an outside-in-pattern of astrogenesis.
    2. Schematics showing neurogenesis and astrogenesis in the adult DG. Comparable to neurogenesis, astrogenesis is a dynamic process. Mostly driven by local astrocyte proliferation, astrogenesis is increased upon running wheel stimulus and diminished upon aging. GZ, granule zone; ML, molecular layer.

    To determine the principles of astrogenesis, the first question posed was on the cellular and temporal origin of DG astrocytes. Starting at early postnatal DG development, we conducted genetic fate-mapping, proliferation analysis, and retrospective birth-dating experiments to reveal at which timepoint the first astrocytes appear and where they come from. Recombination of NestinCreERT2; GFP animals at P0 identified Nestin+ rNSCs as the origin of DG astrocytes. This is supported by clonal analysis showing that highly neurogenic rNSCs expressing the transcription factor HopX can give rise to few astrocytes (Berg et al, 2019). While the first astrocytes appeared as early as P3, we observed a surge of astrogenesis from P10 to P14 (Fig 7A). The next question was how this increase in astrocyte numbers is mediated. Time-lapse imaging of hGFAPeGFP mice demonstrated that rNSCs contribute to astrogenesis not only by proliferation but also by terminal differentiation into astrocytes (Brunne et al, 2010). However, our analysis showed that rNSCs were not the only source of astrocytes in the postnatal DG, but also local astrocytes were able to divide and generate new astrocytes. Notably, such local proliferation of postnatal astrocytes has been previously described for the developing neocortex and spinal cord (Ge et al, 2012; Tien et al, 2012; Shen et al, 2021), where it significantly contributes to the glial increase and brain growth (Bandeira et al, 2009). Investigating the cell type-specific proliferation potential, we observed that the vast majority of proliferating cells at P3 were rNSCs, while at later stages most proliferating cells acquired lineage-restricted precursor identity (neuronal or glial). Hence, we next asked if proliferating astrocytes and rNSCs were lineage-related. Combining fate-mapping with proliferation analysis, we identified Nestin+ rNSCs as a direct source of astrocytes which further proliferate to give rise to postnatally born astrocytes. How often an astrocyte is able to divide, and to which extent these dividing astrocytes can be called precursors, as claimed for other brain regions (Zhu et al, 2011; Takeuchi et al, 2020), needs to be clarified in future studies. Interestingly, our data indicated regional difference in the timing of astrogenesis within the DG, suggesting an outside-in-pattern comparable to what has been reported for DG neurons (Mathews et al, 2010). Since DG neurogenesis precedes astrogenesis (Brunne et al, 2010; Nicola et al, 2015; Bond et al, 2020) it is intriguing to speculate that the region-specific generation of astrocytes follows the maturation state of pre-existing neuronal structures: since early-born neurons layered to the outer DG compartments, this region may require the first astrocytes for further maturation. Our data demonstrate that astrocytes of all DG compartments originate from Nestin+ rNSCs, and it will be interesting to investigate whether the region-specific timing of astrogenesis is a result of an intrinsic program of rNSCs or rather determined by astrocytic requirements of different DG layers at different timepoints.

    A fundamental principle of neocortical development is that neurogenesis and gliogenesis are temporally segregated processes. Very recently, this concept was questioned by a study showing that neocortical rNSCs generate glial cells already from E12 onwards, suggesting a simultaneous generation of neuronal and glial cells. The observed neurogenic-to-gliogenic switch was proposed to rather reflect a downregulation of the neurogenic process as opposed to an upregulation of the glial program (Shen et al, 2021). In line with Bond et al (2020), we demonstrate here that even though neurogenesis starts already at late embryonic stages, neurogenesis and astrogenesis in the postnatal DG are not temporally segregated but occur simultaneously. This finding raises the essential question whether there is a multipotent rNSC in the postnatal DG, in which neuronal versus glial fate decisions are regulated at the single-cell level, or if there are already fate-committed gliogenic and neurogenic rNSC populations? In case of a multipotent precursor, a simultaneous process would require an extra-precise coordination and regulation of neuro- and astrogenesis in single rNSCs (Miller & Gauthier, 2007). On the contrary, if neurogenesis and astrogenesis are driven by fate-committed rNSCs, it will be important to identify the timepoint in which those precursors are segregated. Given that neurogenesis significantly outnumbers gliogenesis at any stage of DG development, the numbers of generated neurons versus astrocytes can be either regulated by the number of fate-determined precursors or by the number of cell divisions that each precursor can undergo. Furthermore, it will be most intriguing to assess (i) to which extent the fate determination is reversible or hardwired, and (ii) whether cell fate is intrinsically determined or shaped by the extrinsic environment. Future studies should explore the mechanisms regulating timing and coordination of simultaneous neuro- and astrogenesis.

    Entering adulthood, most brain regions lose their ability to generate neurons and succumb to gliogenesis, specifically oligodendrogenesis (El Waly et al, 2014). A key feature of the DG is that simultaneous neurogenesis and astrogenesis persist life-long. Work of the past decades identified numerous signaling pathways, transcriptional, epigenetic, and metabolic regulators that exert tight control over the production of new neurons from resident stem cells (Beckervordersandforth et al, 2015; Bond et al, 2015; Kempermann et al, 2015; Beckervordersandforth, 2017). Even though the generation of new astrocytes by adult rNSCs has been described more than a decade ago (Suh et al, 2007; Bonaguidi et al, 2011; Encinas et al, 2011), a comprehensive analysis of adult rNSC lineage progression by intravital live imaging did not identify the generation of new astrocytes by different rNSCs populations (Ascl1+, Gli1+; (Pilz et al, 2018; Bottes et al, 2021)). These seemingly contradictory results may be explained by several underlying causes. First, rNSCs are heterogenous: while Sox2- and Nestin-expressing rNSCs have been reported to give rise to adult-born astrocytes (Suh et al, 2007; Bonaguidi et al, 2011), Ascl1- and Gli1-expressing rNSCs do not (Pilz et al, 2018; Bottes et al, 2021). Second, adult astrogenesis is strongly overwhelmed by adult neurogenesis, suggesting that the numbers of rNSC clones that have been consistently imaged were not enough to capture such a rare event like rNSC-derived astrogenesis (Pilz et al, 2018; Bottes et al, 2021). Third, rNSCs are not the primary source of new astrocytes in the adult brain. In fact, we observed locally proliferating astrocytes in all compartments of the adult DG that were able to divide 1–2 times over a period of 9 days, thereby matching previously reported astrocyte divisions in the postnatal cortex (Ge et al, 2012). These proliferating astrocytes are the main drivers of adult astrogenesis. Interestingly, adult rNSCs were able to give rise to astrocytes which further proliferated corroborating a direct lineage relation as described for postnatal development. Overall, our work opens up a variety of questions that needs to be addressed by future research: is every astrocyte in principle able to proliferate or is this a unique property of a specific astrocyte subpopulation? What triggers an astrocytic division? Is this driven by intrinsic or extrinsic signals or both?

    Voluntary physical activity is the most potent known stimulus to enhance adult neurogenesis in the DG (van Praag et al, 1999a, 1999b) and leads to increased cognitive abilities and improved mood in animals and in humans (van Praag, 2008). Intriguingly, we observed a significant increase in adult astrogenesis upon running wheel stimulus, which was driven by increased proliferation of local astrocytes. Together with evidence that enriched environment, another pro-neurogenic stimulus, evokes a similar increase in astrogenesis (Williamson et al, 2012; Singhal et al, 2020), our data suggest that adult astrogenesis is a dynamic process able to adapt to environmental stimuli (Fig 7B). However, even though total numbers increased, the percentage of neurons and astrocytes among all newly generated cells did not differ between standard housing conditions and running wheel. Even more, this ratio matched the overall occurrence of neurons and astrocytes in the adult DG, indicating a tightly regulated balance between both cell types under different conditions. Since astrocytes are responsible for metabolic and structural support, as well as proper rNSC function and neuronal maturation (Song et al, 2002; Lie et al, 2005; Perea & Araque, 2007; Suzuki et al, 2011; Araque et al, 2014; Ehret et al, 2015), one can hypothesize that a continuous supplement of neurons also requires more astrocytes to maintain proper niche function. This raises the intriguing possibility that not only neurogenesis but also astrogenesis may significantly contribute to hippocampal plasticity upon complex behavioral stimuli. A key question here is which mechanisms regulate astrogenesis? According to a recent publication, astrogenesis in the adult diencephalon is mediated by SMAD4-signaling (Ohlig et al, 2021). SMAD4 is a transcription factor downstream of the TGFβ and BMP signaling pathways (Luo, 2017), which is involved in the regulation of rNSC functions (Mira et al, 2010) and astrocyte differentiation (Mabie et al, 1997; Stipursky et al, 2014), and it is tempting to speculate that SMAD4 also plays a role in DG astrogenesis. Notably, voluntary exercise induced the upregulation of many genes involved in gliogenesis, glial cell differentiation, and migration, including the pro-astrocytic transcription factors (Stat3, Sox9, and Id4), components of Notch and Sonic hedgehog (Shh) signaling pathways (Hes1, Hes5, Shh, and Smo) as well as receptors for growth factors (Fgfr2). Of note, scRNA-seq by 10X Genomics captures predominantly highly expressed genes, and cell isolation per se may induce transcriptional changes (van den Brink et al, 2017), emphasizing the need to validate candidate factors by orthogonal methods such as in situ hybridization. Nevertheless, all of these represent well-suited candidates for regulating the enhanced proliferation of local astrocytes, and it will be interesting to address their functions in future studies.

    Aging is a systemic degenerative process and is associated with a decrease in the regenerative properties. Upon aging, a massive decline of newly generated neurons has been described together with detrimental effects on neuronal maturation and an exhaustion of the rNSC pool (Kuhn et al, 1996; Seki, 2002; Garcia et al, 2004; Heine et al, 2004; Encinas et al, 2011). Notably, we observed that the ratio between newly generated neurons and astrocytes was shifted in aging animals toward astrogenesis. This was predominantly mediated by a dramatic decrease in neurogenesis and not by an increase in astrogenesis. In fact, we observed an overall decrease in astrogenesis upon aging, but the decrease was significantly milder (50%) than the decline of neurogenesis (95%). Also under pathological conditions, the production rate of neurons and astrocytes by rNSCs is shifted in favor of astrocytes (Woodbury et al, 2015). These astrocytes may not necessarily derive from astrocytic divisions, but rather from terminal differentiation of rNSCs into astrocytes as suggested by the “disposable stem cell model” (Encinas et al, 2011). Here, we report that replenishment of the astrocytic compartment in aging animals is also driven by a substantial number of dividing astrocytes. Why does the aging niche still undertake the effort to produce new astrocytes while neurogenesis is seized up? Interestingly, scRNA-seq analysis revealed that many genes potentially upregulated in astrocytes of the aging DG appeared to be involved in synapse organization, presynaptic assembly, axogenesis, and axon guidance. This suggests that astrocytes in the aged DG may be rather maintaining synaptic connection and stabilizing existing neural circuitries than forming new synapses to integrate newborn neurons into DG circuitries. Here, it is interesting to note that scRNA-seq analysis of aging astrocytes from non-neurogenic brain regions identified genes involved in synapse elimination (Boisvert et al, 2018). To which extent this discrepancy may be explained by the specific plasticity of the hippocampal niche will be interesting to reveal in future studies. Moreover, GO-term analysis hinted toward enhanced regulation of cell communication and cell junction assembly which let us to speculate that a key purpose of astrocytes in the aging DG may be to preserve existing cellular structures to counteract aging-induced degenerative processes.

    This discussion highlights the necessity of shedding light on the processes of astrogenesis and its regulation as many questions remain pending. Using the DG as a model system, we here provide a comprehensive description of astrogenesis from development to age. Our work serves as a sound basis to functionally assess astrocyte generation and dynamics under neurodevelopmental, neurodegenerative, and neuropsychiatric disease conditions. A comprehensive understanding of the contribution of astrogenesis to the pathology of such diseases will help to develop novel astrocyte-based treatment options.

    Materials and Methods

    Reagents and Tools table

    Reagent/Resource Reference or Source Identifier or Catalog Number
    Experimental models
    NestinCreERT2; CAG CAT GFP (Mus Musculus) Nakamura et al (2006); Yamaguchi et al (2000)
    NestinCreERT2; YFP (Mus Musculus) Yamaguchi et al (2000); Srinivas et al (2001)
    hGFAPeGFP (Mus Musculus) Nolte et al (2001)
    hGFAP-RFP (Mus Musculus) Hirrlinger et al (2005)
    Antibodies
    Primary antibodies (dilution; required pre-treatment); in vivo RRID
    Rabbit anti-ACSBG1 (1:400; antigen retrieval) Abcam AB_2222394
    Rabbit anti-ALDH1L1 (1:400; antigen retieval) Abcam AB_10712968
    Rat anti-BrdU (1:200; BrdU pre-treatment) Serotec AB_609566
    Guinea pig anti-DCX (1:1,000) Millipore AB_304558
    Chicken anti-GFAP (1:500) Abcam AB_304558
    Mouse anti-GFAP (1:500) Merck AB_477010
    Rabbit anti-GFAP (1:500) Agilent AB_2811722
    Chicken anti-GFP (1:500) Aves AB_10000240
    Goat anti-GFP (1:500) Scigen AB_2333101
    rat anti-KI67 (1:100) Thermo Fisher Scientific AB_10854564
    Mouse anti-MCM2 (1:500; antigen retrieval) BD Bioscience AB_2141952
    Rabbit anti-MCM2 (1:500) Cell Signalling Technologies AB_2142137
    Chicken anti-NESTIN (1:500) Aves AB_10805379
    Mouse anti-NESTIN (1:300) Merck AB_94911
    Mouse anti-NEUN (1:100) Merck AB_2298772
    Mouse anti-S100β (1:500) Merck AB_2665776
    Goat anti-SOX2 (1:300) Santa Cruz AB_2286684
    Rat anti-TBR2 (1:250; antigen retrieval) Thermo Fisher Scientific AB_11042577
    Primary antibodies (dilution; required pre-treatment); in vitro RRID
    Mouse anti-GFAP (1:200) Sigma-Aldrich AB_477010
    Mouse anti-βIII-TUBULIN (1:1,000) Sigma-Aldrich AB_477590
    Secondary antibodies (dilution: all 1:400; host: donkey); in vivo Cat. Number and/or RRID
    α-rabbit Alexa405 Abcam ab175649; AB_2715515
    α-mouse Alexa405 ThermoFisher Scientific A48257; AB_2884884
    α-goat Alexa405 ThermoFisher Scientific A48259; AB_2890272
    α-mouse Alexa488 Jackson ImunoResearch Laboratories 715-545-150; AB_2340846
    α-goat Alexa488 ThermoFischer Scientific r A-11055; AB_2534102
    α-rabbit Alexa488 Jackson ImunoResearch Laboratories 711-545-152; AB_2313584
    Streptavidin conjugated Alexa488 ThermoFischer Scientific S11223; not available
    α-mouse Alexa647 Biolegend 406414; AB_2563202
    α-chicken Alexa647 Jackson ImunoResearch Laboratories 703-605-155; AB_2340379
    α-chicken Biotin Jackson ImunoResearch Laboratories 703-065-155; AB_2313596
    α-goat Biotin Jackson ImunoResearch Laboratories 705-065-147; AB_2340397
    α-chicken CF488A Biotium 20166; AB_10854387
    α-guinea pig CF633 Biotium 20171; AB_10852673
    α-mouse Cy3 Jackson ImunoResearch Laboratories 715-165-150; AB_2340813
    α-rabbit Cy3 Jackson ImunoResearch Laboratories 711-165-152; AB_2307443
    α-rat Cy3 Jackson ImunoResearch Laboratories 712-165-153; AB_2340667
    α-chicken Cy3 Jackson ImunoResearch Laboratories 703-166-155; AB_2340364
    α-goat Cy3 Jackson ImunoResearch Laboratories 705-165-147; AB_2307351
    α-guinea pig Cy3 Jackson ImunoResearch Laboratories 706-165-148; AB_2340460
    Streptavidin conjugated Cy3 Jackson ImunoResearch Laboratories 016-160-084; AB_2337244
    α-rat Cy5 Jackson ImunoResearch Laboratories 712-175-153; AB_2340672
    α-rabbit Cy5 Jackson ImunoResearch Laboratories 711-175-152; AB_2340607
    α-mouse Cy5 Jackson ImunoResearch Laboratories 715-175-151; AB_2340820
    α-guinea pig FITC Jackson ImunoResearch Laboratories 706-095-148; AB_2340453
    Secondary antibodies (dilution: all 1:400; host: donkey); in vitro Cat. Number and/or RRID
    α-mouse Alexa Fluor 488 (1:1,000) Thermo Fisher Scientific A-21141; AB_2535778
    α-mouse Alexa Fluor 647 (1:500) Thermo Fisher Scientific A-21240; AB_2535809
    Oligonucleotides and sequence-based reagents
    Mouse line Primer sequence
    NestinCreERT2 fwdGTTTCACTGGTTATGCGGCG
    revGAGTTGCTTCAAAAATCCCTTCC
    CAG CAT GFP fwdCTGCTAACCATGTTCATGCC
    revGGTACATTGAGCAACTGACTG
    YFP fwdAAAGTCGCTCTGAGTTGTTAT
    revWTGGAGCGGGAGAAATGGATATG
    hGFAPeGFP fwdCAGGTTGGAGAGGAGACGCATCA,
    revCAGCTTGTGCCCCAGGATGT
    hGFAP-RFP mRFP4110:CCCCGTAATGCAGAAGAAG
    mRFP4111:CTTGGCCATGTAGGTGGTCT
    Chemicals, enzymes and other reagents
    4´,6-diamidino-2-phenylindole (DAPI) Sigma Aldrich D8417
    Aqua Poly/Mount Polysciences 18606
    B27 Thermo Fisher Scientific 17504044
    Bromodeoxyuridine Sigma-Aldrich B5002
    L-Glutamine Sigma-Aldrich G8540
    HEPES Sigma Aldrich H3375
    Hyaluronidase Sigma-Aldrich H3884-100mg
    Paraformaldehyde Carl Roth 335
    Penicillin Sigma-Aldrich A5955
    Poly-D-lysine Biochrom AG L7240
    Sunflower seed oil Sigma-Aldrich S5007
    Tamoxifen Sigma-Aldrich T5648
    TissueTec Leica Biosytem 14020108926
    Triton X-100 Carl Roth 3051
    Trypsin Sigma-Aldrich T9201-500mg
    Trypsin/EDTA Gibco 11560626
    Tween 20 Sigma-Aldrich P9416
    Software
    Adobe Illustrator Adobe https://www.adobe.com/creativecloud.html
    AxioVision 4.7 software Carl Zeiss https://www.micro-shop.zeiss.com/de/de/system/axiovision+software-software+axiovision-software/6014/
    Fiji ImageJ Schindelin et al (2012) https://fiji.sc
    GraphPad Prism 9.0 Graphpad Software, Inc https://www.graphpad.com/scientific-software/prism
    Panther online tool Mi et al (2019) http://www.pantherdb.org
    Seurat R package (version 3.1.0) Butler et al (2018); Stuart et al (2019)
    TTT for single cell tracking Hilsenbeck et al (2016)
    Other
    AAV2/9-hsyn-jGCaMP7s-WPRE AddGene 104487
    ApoTome.2 (Axio Observer 7; Axiocam 503; Colibri 7 LED light source) Carl Zeiss NA
    Cell observer Carl Zeiss NA
    Cell Ranger (version 2.1.1) 10X Genomics, Pleasanton, CA NA
    Chromium Controller and the Chromium Single Cell 3' Reagent Kit v2 10X Genomics, Pleasanton, CA NA
    Cryotome Leica Microsystems NA
    Dental cement Superbond C&B, Sun Medical 170447
    FastQC (version 0.11.8) Babraham bioinformatics NA
    Leica SP8 MP microscope Spectra Physics NA
    Sliding microtome Leica Microsystems NA
    Superglue Pattex ultra, Henkel NA
    Zeiss LSM 780 confocal microscope Carl Zeiss NA

    Methods and Protocols

    Experimental model and subjected details

    All experiments were carried out in accordance with the European Communities Council Directive (86/609/EEC). Animal experiments were approved by the Government of Middle-Franconia and Upper Bavaria. If not further specified, mice were group-housed in standard cages with ad libitum access to food and water under a 12-h light/dark cycle. Only mice used for the running paradigm were held singly in standard cages with additional access to a running wheel. Distance of running was precisely measured by tachometers attached to the running wheels (Conrad Digispeed 5, Cat#853147). During development, NestinCreERT2; GFP animals (Yamaguchi et al, 2000; Nakamura et al, 2006) were used for fate-mapping, birth-dating, and proliferation experiments. 8-week-, 14-month-, and 21-month-old hGFAPeGFP animals (Nolte et al, 2001) were used to investigate astrogenesis and neurogenesis by BrdU birth-dating in the adult and aging DG. To further confirm adult astrogenesis, 9-week-old NestinCreERT2; Rosa26YFP animals (Yamaguchi et al, 2000; Srinivas et al, 2001) were analyzed. Adult and aging fate-mapping experiments were conducted in NestinCreERT2; GFP animals. In vivo and in vitro imaging experiments were carried out in hGFAP-RFP mice (Hirrlinger et al, 2005). Male and female mice were used for experiments. Whenever possible, gender-matched mice from one litter were randomly assigned to treatments to correct for batch biases. All animals have been described previously, and all efforts were made to minimize the number of animals used, and their suffering.

    Genotyping

    Genotyping of transgenic mice was performed using polymerase chain reaction (PCR) from DNA extracted from small tissue samples (ear biopsies). The following primers were used for genotyping:

    NestinCreERT2: fwd GTTTCACTGGTTATGCGGCG, rev GAGTTGCTTCAAAAATCCCTTCC; CAG CAT GFP: fwd CTGCTAACCATGTTCATGCC, rev GGTACATTGAGCAACTGACTG; Rosa26YFP: fwd AAAGTCGCTCTGAGTTGTTAT, rev GGAGCGGGAGAAATGGATATG, hGFAPeGFP: fwd CAGGTTGGAGAGGAGACGCATCA, rev CAGCTTGTGCCCCAGGATGT hGFAP-RFP: mRFP 4110: CCCCGTAATGCAGAAGAAGA, mRFP 4111: CTTGGCCATGTAGGTGGTCT.

    Tamoxifen administration

    Tamoxifen (Sigma-Aldrich, Cat# T5648) was dissolved at a concentration of 10 mg/ml in 10% ethanol and 90% sunflower seed oil under constant agitation in the dark at room temperature. To induce recombination, perinatal (P0) mice were subcutaneously injected with freshly prepared 40 mg/kg tamoxifen twice (12 h apart). 8-week-old, 14-month-old, and 21-month-old animals were intraperitoneally injected with freshly prepared 40 mg/kg tamoxifen every 12 h for five consecutive days.

    BrdU administration

    Bromodeoxyuridine (BrdU, Sigma-Aldrich, Cat# B5002) was dissolved in sterile 0.9% NaCl solution at a concentration of 10 mg/ml. For developmental birth-dating experiments, P3, P7, P14, and P21 animals were intraperitoneally injected once with 50 mg/kg BrdU. For adult birth-dating experiments, BrdU (1 mg/ml) was dissolved together with 2% sucrose in drinking water. BrdU water was held in the dark and changed every 4 days during the experiment.

    Tissue processing

    To collect brain tissue from mice of different ages, the animals were killed and fixed with paraformaldehyde (PFA) by transcardial perfusion, except perinatal stage P3. Killing of the animals occurred in dependence of their age: P3 mice were killed by decapitation, P7 and P10 mice were killed by isoflurane, and from P14 onwards mice were killed using CO2. Transcardial perfusion was conducted by first flushing with phosphate-buffered saline (PBS, pH 7.4) for 5 min at a flow rate of 10 ml/min followed by fixation with 4% PFA (Roth, Cat# 0335) in 0.1 mM phosphate buffer (pH 7.4) for 5 min at a flow rate of 10 ml/min. P7 animals were transcardially perfused using syringes filled with 10 ml PBS (pH 7.4) and subsequently fixed with 10 ml 4% PFA in 0.1 mM phosphate buffer (pH 7.4). For brain tissue collection from P3 mice, no transcardial perfusion occurred. Instead, the brains were removed and fixed in 4% PFA overnight. All PFA-fixed brains were dehydrated and stored at 4°C in 30% sucrose solution.

    For further processing, brain tissue from P3 and P7 animals was immersed in cryostat embedding medium and subsequently frozen using dry ice. The frozen brain tissue was cut into 16-µm-thick sections using a cryotome (Leica Microsystems, Wetzlar, Germany). Cut sections were immediately transferred to coated adhesive glass slides, which were then air-dried for 2 h at room temperature (RT) and then stored at −20°C. From P10 onwards, brain tissue was coronally cut into 50-µm sections using a sliding microtome (Leica Microsystems, Wetzlar, Germany). Cut sections were stored at −20°C in cryoprotection solution filled 96-well plates.

    Histology

    Immunofluorescent stainings were performed either on mounted (P3, P7) or free-floating sections (from P10 onwards). All slices were washed 3 times for 15 min with 1×PBS and then incubated with primary antibodies diluted in blocking solution (1×PBS/3% normal donkey serum/0.05% TritonX100) at 4°C for 72 h.

    The following primary antibodies were used: rabbit anti-ALDH1L1 (1:500, Abcam, AB_10712968), rabbit anti-ACSBG1 (1:400, Abcam, AB_2222394), rat anti-BrdU (1:200, Serotec, AB_609566), guinea pig anti-DCX (1:1,000, Millipore, AB_304558), chicken anti-GFAP (1:500, Abcam, AB_304558), mouse anti-GFAP (1:500, Merck, AB_477010), rabbit anti-GFAP (1:500, Agilent, AB_2811722), chicken anti-GFP (1:500, Aves, AB_10000240), goat anti-GFP (1:500, Scigen, AB_2333101), rat anti-KI67 (1:100, Thermo Fisher Scientific, AB_10854564), mouse anti-MCM2 (1:500, BD Bioscience, AB_2141952), rabbit anti-MCM2 (1:500, Cell Signalling Technologies, AB_2142137), chicken anti-NESTIN (1:500, Aves, AB_10805379), mouse anti-NESTIN (1:300, Merck, AB_94911), mouse anti-NEUN (1:100, Merck, AB_2298772), mouse anti-S100β (1:500, Merck, AB_2665776), goat anti-SOX2 (1:300, Santa Cruz, AB_2286684), rat anti-TBR2 (1:250, Thermo Fisher Scientific, AB_11042577).

    After removal of the primary antibodies, the sections were washed 3 times for 15 min with 1× PBS before incubation with fluorescent secondary antibodies. All secondary antibodies were diluted in blocking solution at a concentration of 1:400. The following fluorophores were conjugated to the secondary antibodies according to the species against which the primary antibodies were raised: Alexa 405 (Thermo Fisher Scientific), Alexa Fluor 488, Alexa Fluor 647, FITC, Cy3, and Cy5 (all Jackson ImmunoResearch). Sections were incubated with secondary antibodies at 4°C overnight. After removal of secondary antibody solution, sections were washed 3 times for 15 min with 1× PBS, and free-floating sections were mounted on slides. All sections were cover slipped with Aqua Poly/Mount (Polysciences, Cat# 18606). Object slides were stored at 4°C in the dark.

    For immunostainings against ACSBG1, MCM2 (ms), ALDH1L1, and TBR2, sections were subjected to antigen retrieval. Therefore, sections were treated with 1 M Tris/EDTA (pH 9) for 5 min at 99°C before the primary antibody was incubated. After the heating step, sections were allowed to cool down for 20 min and washed 3 times for 10 min with MilliQ water, followed by 3 times washing for 10 min with 1×PBS. Immunofluorescent stainings for ACSBG1, MCM2, ALDH1L1, and TBR2 were performed as described above.

    Immunohistochemistry against BrdU requires loosening of the tight DNA structure to allow the BrdU antibody to bind to its antigen. Therefore, we pre-treated the sections with 2 N HCl for 10 min at 37°C. For neutralization, sections were afterwards incubated in 0.1 M borate buffer for 10 min at RT and rinsed three times in 1× PBS. Fluorescent staining for the BrdU antibody was performed as described above. Importantly, if BrdU immunohistochemistry was combined with other markers, their antibody stainings have to be finished before the sections were treated with HCl and borate buffer.

    To better visualize the GFP reporter in slices of NestinCreERT2; GFP mice, we used an additional signal amplification step. After incubation with the primary antibody against GFP, a biotinylated secondary antibody (1:400; Vector Laboratories) was incubated at 4°C overnight. After removal, the sections were rinsed 3 times for 15 min with 1× PBS at RT, followed by incubation of a fluorophore-conjugated streptavidin (1:400; Invitrogen) in blocking solution overnight at 4°C. The staining procedure was finished as described above.

    Microscopy

    All images shown and quantified in this study were taken at the confocal microscope, expect images analyzed for the fate-mapping studies by NestinCreERT2; GFP mice in the adult and aging brain. Confocal images were taken at the Zeiss LSM 780 confocal microscope (Carl Zeiss), which was equipped with four lasers (405, 488, 559, and 633 nm) and 40× (NA 1.46) and 63× (NA 1.4) oil immersion objective lenses. Z-stack thickness differed according to the age of experimental animals: 10–12 µm (P3–P7), 20–25 µm (P10–P14), and 35–40 µm (from P28 onwards). For quantification, the 40× oil immersion objective was used, and the step size between z-stacks was always 2 µm. Representative pictures and single cells were captured with 63× oil immersion objective with a z-stack size of 1 µm. All confocal images were captured with standard settings: The number of total pixels per image and the color depth were set to 1024 × 1024 and 16 bit, respectively.

    For adult and aging fate-mapping experiments, quantification images were taken using a Zeiss inverted Axio Observer 7 with ApoTome.2 equipped with an Axiocam 503, a Colibri 7 LED light source and 20× objective (NA 0.8). Z-stack thickness was 35–40 µm with a steps size of 2 µm. Apotome images were obtained with the standard number of total pixels and the color depth of 1936 × 1460 and 16 bit, respectively. All images were processed using Fiji ImageJ (Schindelin et al, 2012). No additional ImageJ plugins were used.

    Quantification and statistical analysis

    Quantification of total cell numbers

    Quantification of total cell numbers was conducted using confocal images of 3–4 sections containing DGs from 3–6 different animals. The exact values of biological replicates (n) are depicted in the tables. Co-expression of cell type-specific protein expression with markers for generation (BrdU), proliferation (KI67/MCM2), and recombination (GFP) was manually counted and calculated per area, which was measured using the ImageJ software. Differences in z-stack thickness were included in the calculation per area. The investigator was blinded during the assessment of the results. Only animal identification numbers were visible, but no treatment information.

    Statistical analysis

    Data were analyzed using GraphPad Prism 9.0. Following normal distribution, two-sample comparisons were conducted by using unpaired Student's t-tests, and multiple comparisons were performed by one-way ANOVA followed by a Tukey post hoc test. The statistical significance level α was set to 0.05. The results are represented as mean ± SEM. The number of biological replicates (n) is specified for each analysis in the tables.

    In vitro imaging of SEZ-derived NSC-cultures

    SEZ cell culture

    SEZ cultures were prepared from the adult SEZ of young adult (8–12 weeks) hGFAP-RFP mice. Briefly, the tissue was enzymatically dissociated in 0.7 mg/ml hyaluronic acid (Sigma-Aldrich) and 1.33 mg/ml trypsin (Sigma-Aldrich) in Hanks’ Balanced Salt Solution (HBSS; Invitrogen) with 2 mM glucose at 37°C for 30 min. Dissociation was stopped by adding an equal volume of an ice-cold medium consisting of 4% bovine serum albumin (BSA; Sigma-Aldrich) in Earle’s Balanced Salt Solution (EBSS; Invitrogen), buffered with 20 mM HEPES (Invitrogen). Cells were then centrifuged at 200 g for 5 min, resuspended in ice-cold medium consisting of 0.9 M sucrose (Sigma-Aldrich) in 0.5× HBSS, and centrifuged for 10 min at 750 g. The cell pellet was resuspended in 2 ml ice-cold medium consisting of 4% BSA in EBSS buffered with 2 mM HEPES, and the cell suspension was placed on top of 12 ml of the same medium and centrifuged for 7 min at 200 g. The cell pellet was finally resuspended in DMEM/F12 Glutamax (Gibco) supplemented with B27 (Thermo Fisher Scientific), 2 mM glutamine (Sigma), 100 units/ml penicillin (Sigma-Aldrich), 100 µg/ml streptomycin (Invitrogen), buffered with 8 mM HEPES (Sigma-Aldrich), and cells were plated on poly-D-lysine (Biochrom AG) coated coverslips at a density of 200–300 cells per mm2.

    Immunocytochemistry

    Cell cultures were fixed in 4% PFA in PBS for 15 min at room temperature and processed for antibody staining. Antibodies used were as follows: mouse IgG2b anti-βIII-TUBULIN (1:1,000; Sigma-Aldrich) and mouse anti-GFAP (1:500; Sigma-Aldrich). Secondary antibodies were chosen according to the primary antibodies and were coupled to Alexa488 and Cy3 antibodies and coverslips were counterstained with 4´,6-diamidino-2-phenylindole (DAPI; Sigma-Aldrich).

    Time-lapse video microscopy

    Time-lapse video microscopy and single-cell tracking of primary SEZ cultures (Schroeder, 2008; Ortega et al, 2013; Ortega & Costa, 2016; Gómez-Villafuertes et al, 2017; Paniagua-Herranz et al, 2020) was performed with a cell observer (Carl Zeiss) at a constant temperature of 37°C and 8% CO2. Phase contrast images were acquired every 5 min for 6–10 days using a 20× phase contrast objective (Zeiss), an AxioCamHRm camera and a Zeiss AxioVision 4.7 software.

    Single-cell tracking

    Once the time-lapse video microscopy was over, the images exported were converted to the format required. Instructions for the correct processing of images are available for download at: https://www.bsse.ethz.ch/csd/software/tTt-and-qtfy.html. Single-cell tracking was performed using a self-written computer program [TTT; (Hilsenbeck et al, 2016)]. After selecting the position to be tracked and loading all the images of that position, the “Movie Window” and the “Cell Editor Window” appear. In the “Cell Editor Window” wavelength 0 corresponds to brightfield, 1 to FITC, 2 to Cy3, and 3 to DAPI. Once the wavelength 0 was selected, the single-cell tracking was performed in the “Movie Window,” following the Tracking Tool instructions. In this window, different buttons are available to monitor the cell division, cell apoptosis, and lost cell. In the “Cell Editor Window,” these specific cell events will be shown in the lineage tree drawn while the experiment is tracked. After tracking the clone, the nature of the cell progeny was identified by matching the brightfield pictures with the immunofluorescence images (channel 1 represented βIII-TUBULIN, channel 2 GFAP, and channel 3 for DAPI). Movies were assembled using Image J 1.42q (National Institute of Health, USA) software and are played at speed of 1 and 2 frames per second.

    Intravital two-photon imaging of the adult hippocampus

    Hippocampal window surgery

    The hippocampal window surgery procedure was performed as described earlier (Gu et al, 2014; Ulivi et al, 2019). Briefly, 5.5-month-old female mice were anesthetized with MMF (Medetomidine 0.5 mg/kg, Midazolam 5.0 mg/kg, and Fentanyl 0.05 mg/kg) intraperitoneally. 30 min before the surgery, analgesia (Metacam 1 mg/kg and Metamizol 200 mg/kg) was administered orally. The mice were placed on a heating pad set to 37°C and fixed in a stereotactic frame. After shaving and disinfecting the skin using iodine solution (Betadine), a sagittal scalp incision was made. A 3-mm circular craniotomy was made using a dental drill, centered 1.6 mm posterior and 1.6 mm lateral from the midline. The cortex underneath the craniotomy was aspired using a 27 G blunt needle, while flushing the area with ice-chilled saline. The alveus of the hippocampus was left intact. 500 nl of AAV2/9-hsyn-jGCaMP7s-WPRE (AddGene) diluted 1:10 in saline was injected at a depth of 0.3 and 0.7 mm below the alveus using a glass micropipette. The imaging cannula, consisting of 3 × 1.5 mm steel cannula with a 3-mm glass coverslip attached with superglue (Pattex ultra, Henkel), was inserted into the craniotomy and secured with dental cement (Superbond C&B, Sun Medical). A custom-made metal headbar was attached to the skull with dental cement. Analgesia (Metacam) was administered orally 24, 48, and 78 h after the surgery. All procedures occurred in agreement with animal protocols approved by the government of Upper Bavaria.

    In vivo two-photon imaging

    In vivo two-photon imaging followed 4 weeks after the surgery. For the imaging, mice were anesthetized with MMF intraperitoneally and positioned underneath the microscope on a heating pad. Multi-photon microscopy was performed at the Core Facility Bioimaging of the Biomedical Center with a Leica SP8 MP microscope, equipped with a pulsed InSight DS+ laser (Spectra Physics). GFP and RFP excitation was achieved at 910 nm and 1,075 nm, respectively. The objective used was HC IRAPO L 25×/1.00. Voxel size was 0.3 × 0.3 × 5.0 µm, and image dimensions were 1024 × 1024 and field of view measured 306 × 306 µm. Imaging of the same area was performed at day 1, 6, and 9.

    Single-cell RNA sequencing and analysis

    Single-cell isolation of DG tissue and library preparation

    After cervical dislocation, brains were isolated from hGFAPeGFP mice (2–14-month-old) and the DGs were dissected in ice-cold HBSS or PBS. Tissue was enzymatically dissociated with 0.25% Trypsin/EDTA (Gibco) in HBSS containing 2 mM Glucose at 37°C for 30 min. Before and after incubation, the tissue was repeatedly triturated with a fire-polished Pasteur pipette. Enzyme activity was stopped by the addition of equal volume of 4% BSA in Earle’s Balanced Salt Solution (EBSS, Gibco). The cell suspension was filtered through a 70-μm cell strainer and centrifuged at 180 g for 5 min, and the pellet was resuspended in 0.9 M sucrose in 0.5× HBSS (Gibco). After further centrifugation for 10 min at 290 g, the cell pellet was resuspended in 2 ml of Solution 3 and placed on top of 10 ml Solution 3, centrifuged again for 7 min at 130 g. The resulting pellet was then resuspended in filtered PBS. Tissue preparation is also described in (Fischer et al, 2011). We determined cell density using a Neubauer chamber. Libraries were prepared using the Chromium Controller and the Chromium Single Cell 3' Reagent Kit v2 (10X Genomics, Pleasanton, CA) according to the manufacturers’ instructions. Single-cell suspensions were diluted in nuclease-free water according to the manufacturers’ instructions to obtain a targeted cell count of 5,000. Libraries were sequenced as described previously (Lukassen et al, 2018).

    Data processing for scRNA-seq analysis using cell ranger and seurat

    The reads were de-multiplexed using Cell Ranger (version 2.1.1, 10X Genomics). Mkfastg and read quality was determined by FastQC (version 0.11.8, Babraham bioinformatics). The standard Cell Ranger workflow was used for mapping the reads to the mm10 genome (10X Reference 2.1.0, GRCm38, Ensembl 84) and to identify single cells. Common quality control measures for scRNA-seq (gene count per cell, UMI count per cell, percent of mitochondrial transcripts) were calculated using the Seurat R package (version 3.1.0) (Butler et al, 2018; Stuart et al, 2019). The analyses were performed for each condition. Quality control thresholds were set to 100–2,500 genes per cells and < 10% of mitochondrial transcripts. All samples were used for further analysis.

    scRNA-Seq clustering and differential gene expression analysis using Seurat

    Clustering of the cells was performed using the Seurat packages for R following the vignettes of the authors (Guided tutorial—2700 PBMCs for PCA approach, version 3.1.0) (Butler et al, 2018; Stuart et al, 2019). Cluster identity was defined using known marker expression, and astrocytes were identified by the expression of astrocytic markers, that is, Aldoc, Aldh1L1, Sox9 Slc1a2, and Slc1a3. Differentially expressed genes between the different conditions were identified using the MAST algorithm as implemented in Seurat. To adjust for cellular detection rate, we used nCount_RNA as confounding variable (Finak et al, 2015). Very few significantly differentially expressed genes (DEGs) could be identified (determined by adjusted P-values). Therefore, for pathway analysis cells were selected based on their average logarithmic fold chance (avg_logFC). In the comparison of both young non-runners (ctrl) to young runners and young non-runner (ctrl) to aged non-runners, we selected genes with an avg_logFC ≥ 0.25 as being expressed at higher levels in astrocytes of ctrl animals, while genes with an avg_logFC ≤ −0.25 as being expressed at higher levels in astrocytes of running/aged mice. These genes were included for GO-term analysis using the Panther online tool (GO biological process complete) (http://www.pantherdb.org; Mi et al, 2019).

    Data availability

    The data that support the findings of this study are included in the paper and are deposited online (GEO: GSE190399, https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE190399).

    Acknowledgements

    We thank Chichung Lie and the members of his group for helpful discussions and Chiara Rolando and Michael Wegner as members of J.S.’s thesis advisory committee for constructive comments on the project. We further thank Marlen Knobloch and Sebastian Jessberger for sharing their clonal analysis data with us, which was important to develop the initial concept of adult astrogenesis. This work was supported by grants from the German Research Foundation (DFG; BE 5136/2-1 and 1-2 to R.B., INST 410/45-1 FUGG). The research training group 2162 “Neurodevelopment and Vulnerability of the Central Nervous System” of the German Research Foundation (DFG GRK2162/1) supported this work as follows: J.S as an associated fellow and M.-T.W. and J.K. as fellows of the GRK2162. J.W. was supported by the Interdisciplinary Centre for Clinical Research (IZKF), Erlangen. S.L. was funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany’s Excellence Strategy within the framework of the Munich Cluster for Systems Neurology—EXC 2145 SyNergy—ID 390857198 and the Emmy Noether Programme. P.S. was supported by the Graduate School for Systemic Neurosciences GSN-LMU. Felipe Ortega acknowledges grants from the local Government of Madrid (Comunidad de Madrid, Spain) under the Multiannual Agreement with the Universidad Complutense through the Program to Stimulate Research for Young Doctors in the context of the V PRICIT (Regional Programme of Research and Technological Innovation) UCM-CAM (PR65/19-22453) and from the Spanish Ministerio de Ciencia, Innovación y Universidades (MCIU, PID2019-109155RB-I00, BFU2015-70067REDC). The present work was performed in fulfillment of the requirements for obtaining the degree “Dr. med.” to Johannes Weigel. Open access funding enabled and organized by Projekt DEAL.

      Author contributions

      Julia Schneider: Conceptualization; Data curation; Formal analysis; Validation; Investigation; Visualization; Writing—original draft; Writing—review & editing. Johannes Weigel: Formal analysis; Investigation. Marie-Theres Wittman: Formal analysis; Investigation. Pavel Svehla: Formal analysis; Investigation. Sebastian Ehrt: Investigation. Fang Zheng: Investigation. Tarek Elmzzahi: Investigation. Julian Karpf: Investigation. Lucia Paniagua-Herranz: Investigation. Onur Basak: Investigation. Arif Ekici: Investigation. André Reis: Resources; Funding acquisition. Christian Alzheimer: Resources; Funding acquisition. Felipe Ortega: Resources; Supervision; Funding acquisition. Sabine Liebscher: Resources; Supervision; Funding acquisition. Ruth Beckervordersandforth: Conceptualization; Resources; Data curation; Software; Formal analysis; Supervision; Funding acquisition; Validation; Investigation; Visualization; Methodology; Writing—original draft; Project administration; Writing—review & editing.

      In addition to the CRediT author contributions listed above, the contributions in detail are:

      Conceptualization JS, RB; Investigation, JS, JW M-TW, PS, SE, FZ, TE, JK, LPH, OB, AE, RB; Formal analysis, JS, JW M-TW, PS, TE, LPH, RB; Resources and Funding acquisition, OB, AR, CA, FO, SL, RB; Writing-Original draft JS, RB; Supervision, FO, SL, RB. All authors read and approved the manuscript.

      Disclosure and competing interests statement

      All authors declare that the submitted work was performed without any personal, professional, or financial relationships that could be potentially construed as a conflict of interest.

      Supporting Information

      References

        Download PDF